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ABSTRACT
Electronic signals from bedside monitors in University of Virginia’s Neonatal 
Intensive Care Unit (NICU) are routinely collected and stored. The overall goal of 
our research is predictive monitoring: we seek patterns in signals that give early 
warning of impending pathology. This work focuses on apnea (pauses in regular 
respiration), and on periodic breathing (regular cycles of breathing and apnea).
Our examination of apnea events revealed a disturbing number of cases in which 
the cessation of breathing lasted at least 60 seconds. These observations were 
validated, clinical correlations of these events were identified, and a theory was 
developed that partially explains how they occur.
Periodic breathing in neonates is a normal developmental phenomenon. It arises 
when there is instability in the respiratory control system. A mathematical model 
of periodic breathing was developed to analyze the stability of the control system 
in infants. Periodic breathing has long been thought to be benign, however, 
exaggerated durations of periodic breathing may be an indicator of pathology. 
Characterization of periodic breathing has previously been limited to short 
monitoring times in small numbers of infants. An automated system for 
measurement and characterization of periodic breathing was developed and 
applied to 5 years of data from the NICU. The amount of periodic breathing that 
infants had was found to increase with gestational age (up to 32 weeks). Also, 
times of excessive periodic breathing were recorded and clinical correlations 
were sought. A significant increase in periodic breathing in the 24 hours before 
diagnosis of necrotizing enterocolitis was found.
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Introduction and Collection of Data
The University of Virginia’s (UVa’s) neonatal intensive care unit (NICU) 
has been collecting and storing bedside monitor data and clinical information 
continuously since January 2009. This large dataset provides us with the 
opportunity to analyze apnea and periodic breathing in large numbers of infants. 
Our goal is to find new ways to use the data that is routinely measured to predict 
the future state of the patient. We have focused on periodic breathing and Very 
Long Apnea events.
In this chapter we describe the data that is collected and stored. In chapter 
2 we discuss apnea events that lasted for over 60 seconds (Very Long Apnea 
events). We present a mathematical model to describe these events. We show 
that two differential equations govern how the oxygen saturation falls during an 
apnea event and that the rate of the fall of oxygen saturation is determined by 
four constants and initial conditions.
Chapters 3 through 5 focus on periodic breathing. A new method of
detecting periodic breathing is presented in chapter 3. In chapter 4 the model
used to describe the fall of oxygen saturation is expanded to describe periodic
breathing. Periodic breathing has often been modelled in the past, Models of
periodic breathing help us to understand why periodic breathing occurs. Fitting
the model to individual patient may allow us to determine values of physiological
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parameters which are used in the model. Knowledge of these values may allow 
us to discover how parameter values change in an infant during illness which is 
accompanied by periodic breathing. It may also help us to identify infants who 
are at risk because of abnormal values. In chapter 5 we show possible correlates 
of excessive periodic breathing. Up until this time periodic breathing had not 
been quantized in a large number of infants. Our first task therefore is to use the 
method of detecting periodic breathing that is presented in chapter 3 to detect 
periodic breathing in the entire dataset and establish what normal amounts of 
periodic breathing are. Once that has been done we are able to determine which 
infants had excessively high amounts of periodic breathing. We looked at how 
periodic breathing changed before illness was diagnosed to see if rising amounts 
of periodic breathing could be used to detect illness earlier.
Clinical data
The UVa NICU is a quaternary care unit that admits approximately 500 
newborns per year, about half of them preterm and a quarter very low birth 
weight (<1500 grams). The data from bedside monitors (GE Medical, models 
Solar 8000M and I, and Dash 3000, GE Healthcare, Milwaukee) is collected and 
stored via a BedMaster central network server (Excel Medical, Jupiter, FL). The 
UVa NICU had 45 beds when collection of data began. Eight beds were added in 
December 2013.
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The clinical information includes birthdates, gestational ages, birth weight, 
gender, demographic information, admission and discharge times, bed 
assignments, diagnosis dates, respiratory support, and other information 
documented by clinicians.
The bed assignment record is particularly important. The bedside monitor 
data is stored by bed, not by patient. In order to find data for a particular patient it 
is necessary to know what bed that patient was in. Whenever there is ambiguity 
in the bed assignments (e.g. two patients assigned to the same bed at the same 
time or data for a bed that has no patient assigned to it at that time) we are 
unable to use that data.
There are three different ages that are used to describe a neonate. The 
gestational age (GA) is measured in weeks starting from the first day of the 
mother’s last menstrual period. While the infant is in the womb the gestational 
age is increasing but it becomes fixed when the infant is born. Here we always 
use GA to mean the age of the infant at the time of birth, since we are always 
referring to infants after birth. The chronological age is the age of the infant since 
birth. Sometimes the chronological age is given as “days of life”. The 
postmenstrual age (PMA) is the gestational age plus the chronological age. An 
infant that was born at 32 weeks and is one week old has a gestational age of 32 
weeks, a chronological age of 1 week, and a postmenstrual age of 33 weeks.
Premature infants are defined as infants born at less than 37 weeks 
gestational age. Another important factor is the birth weight. Infants who weigh
less than 1000 grams at birth are extremely low birth weight (ELBW) infants, 
while those who weigh less than 1500 grams are very low birth weight (VLBW) 
infants. 90% of infants born at 37 weeks GA (full term) are over 2500 grams 
(Oken et al. 2003).
Respiratory support
There are three main types of respiratory support. The most extreme is 
ventilation. Mechanical ventilation delivers air to the patient through an 
endotracheal tube. The tube is inserted into the infant’s trachea (intubation) when 
the infant is put on mechanical ventilation and removed (extubation) when the 
infant is taken off the ventilator. Continuous positive airway pressure (CPAP) is 
less extreme than ventilation. CPAP helps an infant breathe by applying positive 
pressure to prevent airway closure. The next step in the progression is a nasal 
cannula (NC). A nasal cannula is a lightweight tube that attaches to the patients 
nose. The nasal cannula delivers oxygen to the patient but does not help the 
patient to breathe. Supplemental oxygen may also be administered on any of the 
three types of support. The patient could also be breathing room air without 
assistance.
Diseases in the NICU
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The diseases which are of greatest concern in the NICU are: sepsis, 
necrotizing enterocolitis, intraventricular hemorrhage, bronchopulmonary 
dysplasia, and retinopathy of prematurity.
Sepsis is a blood infection, typically bacterial, but also viral or fungal, 
which can be diagnosed by a blood test. Neonatal sepsis occurs in infants less 
than 90 days old. Early onset sepsis (infection before or during delivery) occurs 
in the first week of life, while late onset sepsis (infection after delivery) occurs in 
infants from day of life 8 to 89. Sepsis is diagnosed by a blood test. In a study in 
2002 of 6215 VLBW infants, 21% developed late onset sepsis, these infants had 
longer NICU stays (mean length of stay: 79 vs 60 days) and a higher mortality 
rate (18% vs 7%) (Stoll et al. 2002). Often the immune response to sepsis can be 
as damaging as the infection itself. In our studies late onset sepsis (LOS) was 
defined as signs of sepsis after three days of birth, together with a positive blood 
culture and a minimum of five days antibiotic therapy.
Necrotizing enterocolitis (NEC) is a condition which involves tissue death 
in the intestines. Infants with NEC typically display immature intestinal lining, low 
perfusion, feeding intolerance, abdominal distention, and bloody stools (Neu, 
Walker 2011). NEC is diagnosed by an x-ray which reveals air in the intestines 
when NEC is present. 1-5% of all infants admitted to the NICU develop NEC and 
7-14% of VLBW infants are affected (Schnabl et al. 2008). NEC typically appears 
in the first three months of life, especially in ELBW infants born at less than 28
5
weeks GA (Schnabl et al. 2008). The mortality rate associated with NEC is 20 to 
30% (Neu, Walker 2011).
Intraventricular hemorrhage (IVH) is bleeding into the brain ventricles. IVH 
is classified as grade I, II, III, or IV. Grades III and IV are defined as severe IVH. 
Bronchopulmonary dysplasia (BPD), abnormal growth of lung tissue, is a chronic 
respiratory condition which primarily affects infants born at less than 28 weeks 
GA (Strueby, Thebaud 2014). Infants were defined as having BPD if they 
required supplemental oxygen at 36 weeks PMA. Retinopathy of prematurity 
(ROP) affects the infant’s eyes and can cause blindness. ROP can be caused 
when oxygen levels are too high in neonates.
i
Bedside monitor data
The data collected from the bedside monitors falls into three categories: 
alarms, waveform data, and vital sign data.
The time, duration, and type of each alarm is recorded. These alarms 
include bradycardia, desaturation, and apnea alarms. Bradycardia alarms 
activate when the heart rate falls below a set limit, typically 90 beats per minute, 
for at least 8 heartbeats. Desaturation alarms activate when the oxygen 
saturation falls beneath a set limit, typically 85%, for at least 5 seconds. These 
alarms continue to sound until the heart rate or oxygen saturation rise above the 
set limit. Apnea alarms activate after 15 seconds of no monitor-detected breaths 
and continue until the monitor detects a breath.
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The waveform data consists of three channels of electrocardiogram (EKG) 
waveforms (sampled at 240 Hz), the chest impedance waveform (sampled at 60 
Hz), and the pulse oximetry (photoplethysmographic) waveform (sampled at 120 
Hz).
The beating of the heart causes electric currents to flow in the body. Three 
leads are attached to the patient to record the EKG. These leads are typically 
placed on the upper right chest, the upper left chest, and above the lower left hip. 
Lead I measures the EKG using the leads on the upper right and left chest. Lead 
II uses the leads on the right chest and above the left hip. Lead III uses the leads 
on the left chest and above the left hip. The 3 EKGs record different voltages 
because the leads are placed in different positions.
The basic pattern of the EKG is a p wave, which appears during 
depolarization before the atria contract, a QRS complex, which also occurs 
during depolarization before the ventricles contract, and a t wave, which occurs 
during repolarization as the ventricles recover after contraction (Figure 1). We 
are mainly concerned with detecting the R peaks. The distance between two R 
peaks is called the RR interval. The heart rate is calculated by taking 1/(RR 





Figure 1: The EKG signal showing the p, q, r, s, and t waves.
The chest impedance is measured using the two leads that are placed 
across the chest for the EKG. A small high frequency (52.6 kHz, outside the EKG 
range) voltage is applied across the chest. This creates a current. The current is 
measured and the chest impedance is calculated by dividing the voltage that is 
applied by the current that is measured. The basic impedance, due to the skin, 
muscles, other tissues, blood, and the lead contacts is on the order of several 
hundred ohms. Air has poor conductivity. The impedance rises as the lungs fill 
with air and falls as the lungs empty (Figure 2). In this way the chest impedance 
signal shows the infant’s breaths. Often the beating of the heart can also be seen 
in the chest impedance as the blood, which has high conductivity, is pumped in
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and out of the heart. The chest impedance is the most important signal for 
research. Unfortunately, this signal is full of artifact.
2 seconds
Figure 2: The chest impedance
1 second
Figure 3: The pulse oximetry signal
The pulse oximetry (Figure 3) is measured using a probe which wraps 
around the infant’s hand or foot. On one side is a light emitter and on the other 
side is a light detector. The probe emits two wavelengths of light (red and 
infrared) which are detected after passing through the hand or foot. The amount 
of light transmitted depends on the wavelength and also on the amount of 
oxygen in the hemoglobin. The signal is pulsed because the volume of blood in 
the arteries increases when the heart beats. The pulse oximetry signal recorded 
by the bedside monitors, and collected by the BedMaster system, is the 
measured amount of red light that is absorbed by the blood. Little information can 
be extracted from this signal. It gives a second measure of heart rate and also, 
when compared with the EKG, a measure of the propagation time of the pulse 
from the heart to the detector. Neither one of these measures are often used. 
However, this signal, together with the corresponding measurement from the 
infrared wavelength, is used to obtain the oxygen saturation of hemoglobin in the 
blood (SpC>2), as described below.
The vital sign data includes heart rate, oxygen saturation (percent of 
saturated hemoglobin), respiration rate, and a second measure of heart rate 
which is calculated from the pulse oximetry (Figure 4). All four signals are 
recorded at 0.5 Hz. The vital sign signals are all averages, typically of the 
previous eight seconds. The heart rate is calculated from the EKG signal. 
Because this is an average heart rate, if an instantaneous heart rate is needed it
10
must be obtained from the EKG signal. The additional heart rate from the pulse 
oximetry is measured using the frequency of the pulses in that signal.
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Figure 4: Vital signals during an apnea event (from 0 to 30 seconds).
Oxygen saturation is the percent of binding sites in the hemoglobin that 
are filled by oxygen molecules. The oxygen saturation is calculated from the 
absorption of red and infrared light measured by the pulse oximeter. When the 
hemoglobin is oxygenated it absorbs more red light, otherwise it absorbs more 
infrared light. The ratio of light absorbed by the two wavelengths is calculated 
and the monitor converts this to a measure of oxygen saturation. Unlike the pulse 
oximetry signal, the pulse does not appear in the oxygen saturation.
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The respiration rate is derived from the chest impedance. This respiration 
rate is often incorrect. When the infant is breathing normally the fluctuations in 
the chest impedance signal due to the air flowing in and out of the lungs are 
much greater than those that are due to the blood being pumped in and out of 
the heart. But when the infant stops breathing the fluctuations due to the blood 
(cardiac artifact) are often mistaken by the monitor for breathing. This is more 
likely to happen when the heart rate falls during apnea. A slower heart rate 
allows more blood to fill the heart during each beat. The increased volume of 
blood in the heart results in greater changes in the chest impedance. These 
changes are more pronounced during apnea because the changes due to 
breathing are absent.
Apnea detection
A new algorithm for detecting central apnea was previously developed by 
Hoshik Lee and validated by clinicians at UVa (Lee et al. 2012). The algorithm 
filters the chest impedance signal (this includes removing the cardiac artifact), 
analyzes the residual fluctuations, and produces, at quarter-second intervals, the 
probability that the infant is having a central apnea event at that moment. Careful 
validation indicated that the algorithm agrees with expert opinion of clinicians in 
about 90% of central apnea events.
The algorithm uses the chest impedance and the EKG waveforms. A 4 
minute window of the chest impedance is Fourier transformed to remove the
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cardiac artifact. If the Fourier transform is taken with a time steps of equal length, 
then the cardiac artifact is a broad peak. Instead, the EKG (with the fewest 
missed beats) is used to determine the time between each heartbeat (the RR 
intervals). The chest impedance is resampled (with 30 points between every 
heartbeat) and the Fourier transform is taken with the unit of time equal to one 
RR interval. Now the cardiac artifact appears as isolated peaks at integer 
frequencies. The peaks are removed and the signal is transformed back. This 
signal is the single filtered chest impedance signal. Next, variations slower than 4 
seconds are removed. These variations are often caused by the infant moving 
and are too slow to be due to breathing. This signal is normalized by dividing it by 
the envelope function of the original chest impedance signal over a 16 minutes 
centered on the 4 minute window. At this point we have the double filtered chest, 
impedance signal.
The double filtered chest impedance signal is used for apnea detection. 
The standard deviation of the signal is taken over a 2 second window every 
quarter second. The standard deviation is high when the infant is breathing and 
low when the infant is not. We use the thresholding function
P  = ------- — ----------1 +  e l2« r -0 4 4 )
to convert from the standard deviation, a, to the probability, P, that the infant is 
having an apnea event at that moment. The constants in the thresholding 
function were obtained through validation of hundreds of samples by clinicians at
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UVa. Application of the thresholding function to the standard deviation signal 
gives the unprocessed probability of apnea signal. This signal has a minimum 
value of zero (when the infant is breathing) and a maximum value of one (during 
apnea). We define the apnea as starting when the signal crosses above 0.1 and 
ending when the signal crosses below 0.1. The signal is processed by removing 
all apnea events that are less than 2 seconds. All apnea events that are less than 
5 seconds are also removed unless there is another apnea within 10 seconds of 
it. The resulting signal is called the processed probability of apnea signal.
This processed signal was used to detect all apnea events lasting for at 
least 10 seconds. Any apnea events that were separated by less than 3 seconds 
were joined together. The processed apnea signal was also used to detect all 
apnea events lasting for at least 10 seconds and accompanied by bradycardia 
and desaturation, presumably due to the apnea. The events are categorized as 
ABDn (Apnea Bradycardia Desaturation), with “n” signifying the minimum length 
of cessation of breathing in seconds (e.g. ABD60 means cessation of breathing 
was 60 seconds or more, and ABD30-40 means cessation of breathing was 
between 30 and 40 seconds). The algorithm's threshold for bradycardia is 
heartrate <100 beats per minute, and for oxygen desaturation is Sp02 <80%, for 
any duration. The heartrate must pass below the threshold within 50 seconds 
after the start of the apnea or before 25 seconds after the end of the apnea. The 
oxygen saturation must pass below the threshold within 55 seconds after the 
start of the apnea or before 38 seconds after the end. We remind the reader that
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the heartrate and oxygen saturation are both averages roughly over the past 8 
seconds. Additionally, the oxygen saturation is measured at the hand or foot and 
there is a delay due to the time it takes for the desaturated blood to travel from 
the lungs to where it is measured. For all infants in our database, we have 
recorded the date, time, and apnea duration of every ABD10 event (10 seconds 
or more).
We used this apnea detection method with 5 years of bedside monitor and 




Very Long Apnea Events
Application of the apnea detection method to the bedside monitor data 
resulted in an unpleasantly large amount of ABD60 tags. We sought to determine 
whether these were truly cases where breathing ceased for over 60 seconds 
and, if so, to explain physiologically why this happens.
More than two decades ago, Southall, et al. reported prolonged apnea and 
bradycardia events in preterm infants in neonatal intensive care units (NICUs) 
(SouthaH et al. 1983). In their study of 14 babies observed for 24 hour periods, 
the authors were disturbed to report cessations of breathing as long as 213 
seconds and that extended apnea events were often not detected or recorded. 
Present practices (Darnall et al. 1997, Finer et al. 2006, Martin, Abu-Shaweesh & 
Baird 2004) hold that any cessation of breathing longer than 10 seconds, if 
accompanied by bradycardia and oxygen desaturation, is an event that should be 
recorded (as is any apnea longer than 20 seconds regardless of bradycardia or 
desaturation). Most events last less than half a minute, either self-resolving or 
terminating when a caregiver stimulates the infant in response to a monitor 
alarm. Apnea events lasting over a minute may reflect abnormal physiology, 
impending illness, alarm failure, and/or failure of bedside clinicians to rescue 
infants from prolonged apneic spells.
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Nearly all very low birthweight infants (VLBW, <1500 grams) experience 
apnea due to inherent brainstem and peripheral chemoreceptor immaturity, and 
pathologic processes such as sepsis, respiratory failure, intracranial hemorrhage, 
and seizures may increase the number or severity of apnea events. Apnea 
events may lead to tissue hypoxemia and, especially if prolonged, severe, or 
frequent, might contribute to adverse short and long-term outcomes, including 
neurodevelopmental impairment. Preventing or minimizing bradycardia and 
desaturation related to apnea should therefore be a priority in NICU care. Steps 
toward this goal include understanding physiologic associations with severe 
apnea, and optimizing monitor alarm systems and caregiver responses.
Much has changed in NICUs since the early reports of prolonged apnea 
events. Bedside monitors have better alarm systems, automated data collection 
and analysis is now possible, and continuous positive airway pressure (CPAP) 
and caffeine to treat apnea are nearly universal for VLBW infants. It may be 
surprising, then, that very long apnea events are still present in NICUs. We 
evaluated the ABD60 tags resulting from the apnea detection method to establish 
that apnea events lasting longer than 60 seconds are stil occurring.
Long apnea in the UVa NICU
All waveform, vital sign, and alarm data from NICU bedside monitors were 
collected and stored for all 1263 patients in the UVa NICU from January 2009 to 
March 2011. For the current analysis, we focused on central apnea events
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associated with bradycardia and desaturation. Our previously developed and 
validated algorithm for detecting central apnea (Lee et al. 2012), presented in 
chapter 2, tagged all detected central apnea events lasting for at least 10 
seconds and associated with bradycardia and desaturation. In 782 of these 
events the apnea lasted for 60 seconds or longer. These events were evaluated 
to determine their validity. Those ABD60 events that survived the validation 
described below are called Very Long Apnea events (VLAs).
After validation we chose to study only very low birth weight infants 
(VLBWs). Two reasons made this a sensible choice: VLBWs have respiratory 
support data recorded, while non-VLBWs do not, and there was only one non- 
VLBW infant who had a validated VLA.
Validation of ABD60 events in the UVa database
782 ABD60 events were tagged in 1263 infants (461 in VLBW infants 
when all waveform signals were available). All tags were subjected to a pre­
validation process which uses the weighted apnea duration, defined as the area 
under the probability of apnea signal divided by the apnea duration, and the 
power in the breathing band to calculate the probability that the tag represents a 
true apnea event. 113 events failed this pre-validation (including 3 tags when the 
infant was being ventilated). An additional 105 tags had waveform data missing 
from the database. All 229 tags that either occurred when the infants was on a
18
ventilator, failed the pre-validation process, or had waveform data missing were 
excluded from the clinical validation.
553 ABD60 tags were subjected to clinical validation by four clinicians who 
are experts on interpretation of the signals. Clinicians assigned each tag to one 
of the following categories: definite ABD lasting at least 60 seconds (VLAs) 
(Figure 5), ABD lasting less than 60 seconds (Figure 6), low frequency 
fluctuations (the source of these fluctuations is unknown) (Figure 7), combination 
of apnea and hypopnea (slow or shallow breathing) (Figure 8), one ABD for 
multiple apnea events (Figure 9), uninterpretable signal (Figure 10), or no central 
apnea. All events categorized as VLAs were assigned a start and end time by the 
clinicians.
Figure 5: An example o f a very long apnea (VLA). Shown are raw and processed 
electronic signals collected from bedside monitors. From top to bottom: heart rate from 
monitor, 100 beat per minute threshold for bradycardia, oxygen saturation and 80% 
threshold for desaturation, raw chest impedance, filtered chest impedance (removing 
cardiac artifact and slow fluctuation). Bottom curve is probability that the infant is 
having an apnea at each moment. This VLA lasts slightly more than 60 seconds. 
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Figure 6: ABD tag starting early. This apnea lasts less than 60 seconds. Signals from top 
to bottom are: heart rate, oxygen saturation, raw chest impedance, fdtered chest 
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Figure 7: ABD tag with low frequency fluctuations in chest impedance. Signals from top 
to bottom are: heart rate, oxygen saturation, raw chest impedance, fdtered chest 
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Figure 8: VLA with combination o f apnea and hypopnea. Signals from top to bottom are: 
heart rate, oxygen saturation, raw chest impedance, fdtered chest impedance, and 
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Figure 9: One ABD tag for two separate apnea events. Signals from top to bottom are: 
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Figure 10: ABD tag with uninterpretable chest impedance signal before and after the 
apnea. Signals from top to bottom are: heart rate, oxygen saturation, raw chest 
impedance, fdtered chest impedance, and probability of apnea.
The following conditions had to be met in order for a tag to qualify as VLA: 
the chest impedance had to be acceptably flat for at least 60 seconds; there 
could be no apparent breaths within the 60 seconds; the event must have been 
accompanied by any duration of bradycardia (<100bpm) and desaturation (< 
80%); the cessation of breathing had to last at least 60 seconds; the filtered 
chest impedance could have no artifacts, no indication of shallow breaths, and no 
twitches in chest impedance which had an associated increase in heart rate; 
there could be no low frequency fluctuations for which there was any apparently 
related increase in heart rate; any episodes of increased heart rate could not be 
associated with a breath or low frequency fluctuations; there had to be 
acceptable breathing in the chest impedance signal before and after the event.
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Samples were reviewed by four clinicians in groups of two. The two 
clinicians in each group validated events separately. If a sample was categorized 
as a VLA by one clinician and not the other, then all four reviewers discussed the 
sample until a consensus agreement was reached. Through this process, 90 
events were categorized as VLAs. 86 of these occurred in 29 VLBW infants, 3 
occurred in a single non-VLBW infant, and 1 occurred in an unidentified infant 
(no patient assigned to that bed at the time of the event). We focus our 
evaluation of VLAs on the 86 events that occurred in identified VLBW infants.
This decision allowed us to include respiratory support data for all evaluated 
events, since only VLBW infants had respiratory support data available.
Our requirements for VLA were very stringent, because our goal was to 
show indisputably that ABD60 events do truly exist. Many tagged ABD60s that 
did not meet these requirements may still be true ABD60 events. Of the 461 
ABD60 events in VLBW infants for which all waveform signals were available, 20 
had poor and uninterpretable signals and 38 were recognized as apnea events of 
less than 60 seconds duration. These 58 events were excluded. The remaining 
317 events can be considered “questionable” ABD60 events. We consider these 
“questionable” cases to be examples of failure of respiratory regulation lasting at 
least 60 seconds, but we do not include them in our category of indisputable 
VLAs. Using our stringent requirements we estimate that VLAs occur at a rate of 
1 per 70 infant-days, while the estimate if we include questionable events is over 
four times larger, 1 per 16 infant-days.
23
Shorter apnea samples
We collected random samples of 10-20 second and 30-40 second ABD 
events. 100 ABD10-20s and 100 ABD30-40s were collected from infants who 
also had VLAs. The rate of fall of heart rate and oxygen saturation (Sp02) during 
these shorter events were compared to the rates of fall during VLAs. 100 ABD10- 
20s and 100 ABD30-40s were also collected from infants who never had an 
ABD60 tag and whose post-menstrual age (PMA) at the time of the event was 
less than 34 weeks. These events were compared to the shorter events in VLA 
infants. An additional requirement was that the shorter ABDs did not occur during 
periodic breathing, as periodic breathing could affect pre-apnea heart rate and 
oxygen saturation.
Patient characteristics and clinical associations
As stated above, ABD60 events in 335 VLBW infants were subjected to 
the validation process (described previously). 86 events in 29 infants were 
determined to be Very Long Apnea events. The estimated frequency of these 
VLAs is 1 per 70 infant-days. The number of events per infant ranged from 1 to 
19 (Figure 11).
In most respects, infants with VLAs were not significantly different from 
other VLBW infants (Table 1). Infants with VLA events had significantly longer 
NICU stays than those without, and their average gestational age was slightly 
lower (p=0.09) (Table 1). Over half of the VLA infants fell in the GA range of 25-
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27 weeks (Figure 12a) and 84% of VLAs occurred less than 4 weeks from birth 
(Figure 12b). 79% of the VLAs occurred while infants were on continuous 
positive airway pressure (CPAP), usually with supplemental oxygen (Figure 13). 
All 29 infants were on caffeine therapy at some time during their NICU stay, one 
VLA occurred 4 days after caffeine was discontinued. Two infants had VLA on the 
day of birth, prior to caffeine being initiated. No VLA events occurred within 10 
days of NICU discharge.
Number of VLAs by Infant 
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Figure 11: Number of VLA events per infant (Infant 1 had 19 events, and 29 infants had 
at least 1 event). (Reproduced from Mohr et al. 2015b.)
Infants with clinical associations 
Infants with no clinical associations
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Table 1: Characteristics of VLBW Infants with and without validated VLA events






(weeks) 26.5 ± 1.9 27.5 ±3.1 0.09
Birth weight 
(grams) 952 ± 249 988 ± 299 0.53
ELBW 19(66%) 150 (49%) 0.12
Male 14 (48%) 154 (50%) 0.85
Mechanical 
ventilation at any 
time
23 (79%) 214(70%) 0.39
Death before 
NICU discharge 1 (3%) 31 (10%) 0.34
Length of NICU 
stay (days) 78 ±27 63 ±42 0.02
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Figure 12: (a) Histogram of number o f VLA events and number o f VLA infants 
versus gestational age (GA) at birth. For comparison the number o f infants versus 
GA for the entire population of Very Low Birth Weight (VLBW) infants in our 
database is also shown. For example, among 26-week GA infants, eight o f the 37 
VLBW infants had at least one event, and there were 15 total events, (b) 
Histogram o f number o f VLA events versus chronological age (CA) at time of 
event for those infants having one or more VLAs (left scale). For comparison the 
number of VLBW infants who were in the UVa NICU at that CA is also shown 
(right scale). For example, at one week of age, there were 25 VLAs among 266 
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Figure 13: Histogram showing respiratory support o f VLA infants at the times o f their 
events. From left to right: room air, nasal cannula without supplemental oxygen, nasal 
cannula with supplemental oxygen, CPAP without supplemental oxygen, and CPAP with 
supplemental oxygen. Most VLA events occurred while infants were on CPAP with 
supplemental oxygen. (Reproduced from Mohr et al. 2015b.)
In 18 of the 29 infants with VLAs, medical record review identified clinical 
conditions (separate from prematurity which was present in all subjects) that 
were possibly associated with apnea (Table 2). Ten infants were receiving 
antibiotics at the time of the VLA, four were started on antibiotics within 24 hours 
of the VLA for suspected sepsis (although none had proven septicemia), seven 
were intubated within 12 hours of the VLA, and six had other conditions. The 
infant with the greatest number of events (nineteen) died suddenly and 
unexpectedly for unclear reasons. He was stable on full feeds, CPAP and 
caffeine at the time of death, and autopsy was declined. The other infant with a
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large number of events (12 VLAs at 2-3 weeks of age) was on erythromycin for 
severe gastroesophageal reflux. No VLAs occurred beyond 18 days of age and 
he was discharged home at 78 days of age. We could see no systematic 
differences in the characteristics of the VLAs associated with these different 
clinical situations.
Table 2. Clinical conditions in infants with VLAs
(Reproduced from Mohr et al. 2015b.)_____ ______
# of infants Clinical association GA #VLAs PMA




ventricular tap performed 
prior to VLA cluster
26 3 31
1 Grade IV intraventricular hemorrhage 26 2 30
1 On prostaglandins for congenital heart disease 29 3 31
2 On medication for severe GE reflux 25 3-12 27-29
4
Antibiotics started for 
suspected sepsis within 
24h of VLA
23-29 1-19 26-31
10 Receiving antibiotics at time of event 25-30 1-19 25-32
7 Intubated within 12h of VLA 23-29 1-4 24-31
11 None identified, other than prematurity 24-31 1-5 27-34
For the other 11 infants (38% of the VLA infants), we could not identify a 
clinical condition that appeared to be a cause or effect or to have an association
with the VLA. These 11 differ only slightly from the 18 with clinical associations. 
The infants without clinical associations had slightly higher GAs, but the 
difference was not significant (p=0.16). Not surprisingly, these 11 infants also had 
shorter stays in the NICU than the other 18 infants did (p=0.02). There were no 
differences in the rate of fall of heart rate and oxygen saturation between VLA 
infants with clinical associations and those without.
Table 3. Apnea rates







% of all 
VLBW 
babies
Tags per baby- 
day of data
Group I: Infants 
with Indisputable 
60 second VLAs
6,617 29 9 4.29
Group N: Infants 
who Never had a 
ABD 60
6,300 199 59 1.52
Infants who never 
had a computer- 
detected ABD 10 
(included in Group 
N)
0 62 19 0
All VLBW Infants: 30,793 335 100 2.94
Apnea rates in study group and comparison group
The 29 infants who had VLAs formed our study group. All infants who 
never had an ABD60 tag formed our comparison group. The total numbers of 
ABD10 tags for the study group and the comparison group of VLBW infants are 
in Table 3. Infants who had VLAs also had many ABD10 events. The majority of
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infants never had any ABD60 events; these infants also had a lower rate of 
ABD10 events.
Bedside monitor alarms in VLA events
Bedside monitor apnea alarms are designed to sound 15 seconds after 
cessation of breathing. Apnea alarms sounded in 66% of VLAs, but failed to do 
so in 34%. Bradycardia alarms activated in 57% of VLAs, and low oxygen alarms 
activated in 81%. At least one alarm activated in 97% of VLAs. The monitors use 
slightly different criteria than the apnea algorithm for bradycardia and 
desaturation, so it is not surprising that these alarms did not go off during all VLA 
events.
For the cases in which the bedside monitor sounded an apnea or 
bradycardia alarm, Figure 14 shows histograms of the time from the start of the 
computer-detected apnea to the alarm, and of the time from the alarm to the end 
of the detected apnea.
If the bedside apnea alarm sounded, it did so rather promptly, typically less 
than 25 seconds from the beginning of the computer-detected apnea. If the 
bedside bradycardia alarm sounded, it usually occurred long after the cessation 
of breathing (Figure 14), consistent with the slow fall of heart rate in these 
events. Shortly after the bradycardia alarm sounded (but frequently quite long 
after the apnea alarm), the apnea ended.
It appears that bedside caregivers respond quickly to bradycardia alarms, 
which are “crisis” alarms on the monitors in the UVa NICU (in contrast to apnea
31
“warning” alarms), but as a result of the slow fall of heart rate these alarms are 
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Figure 14: (a) Time from cessation o f breathing to bedside apnea or bradycardia alarm, 
and (b) time from alarm to end of apnea for VLAs. If the apnea alarm sounds, it usually 
does so within about 20 seconds after the beginning of the apnea. In VLA events, the 
heart rate falls slowly, so the bradycardia alarm is much delayed, typically sounding 60 
to 70 seconds after the apnea begins. Apneas usually end a short time after the 
bradycardia alarm. (Reproduced from Mohr et al. 2015b.)
positives, would be helpful to NICU personnel and might have a significant 
beneficial effect on the health of infants by reducing hypoxemia and bradycardia.
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Short and long apnea events in VLA Infants
A striking characteristic of VLAs is that heart rate and oxygen saturation 
fall later and more slowly than they do during shorter ABD events. This can be 







-20 0 20 40 60 80 100 120
time from start of apnea (seconds)
Figure 15: In VLAs oxygen saturation and heart rate fall slowly. We show the average 
heart rate and oxygen saturation (SpC>2) for all o f the VLAs (ABD60-80, n=46, and 
ABD80, n—40). For the shorter events we took a random sample of ABD10-20 (h=100) 
and ABD30-40 (n=100) from this same group of infants. The start o f the computer- 
detected apnea is t=0. The black curves, barely distinguishable from the observed Sp02 
curves, are based on the theory from equations 2.1 —2.5 with constants given in Table 4. 
Vertical lines indicate ±1 standard error o f the mean. (Reproduced from Mohr et al. 
2015b.)
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100 ABD 10-20 and 100 ABD 30-40 events were randomly selected from 
infants who had VLAs. The events were chosen such that the infant’s PMA was 
less than 31 weeks at the time of the event. The average of multiple events is 
plotted, and the standard error of the mean is marked. (The heart rate fell below 
100 BPM and the oxygen saturation fell below 80% in every individual event. 
However, these thresholds were crossed at different times in different events, so 
the averages do not necessarily fall below the thresholds.)
Measures of severity
One difficulty in assessing the impact of a VLA arises from the slow fall of 
Sp02- Because of this slow fall it is not clear that the duration of the event is a 
good measure of its severity.
Another measure that can be used to determine the severity of the VLA is 
the area between the Sp02 curve and a chosen threshold. This area is related to 
the oxygen deficit in the blood. For example, if normal oxygen transport is M 
ml/minute, and the area between the Sp02 curve and the baseline value is A %- 
minutes, then M-A/100 is the oxygen deficit resulting from the apnea. We can 
also make a similar measurement with heart rate.
The area measured depends upon the threshold that is chosen. Measures 
were made with two different thresholds in order to determine if the results were 
consistent. The first threshold was chosen to be the lesser of 92% or the 
measured pre-apnea baseline (PAB). The PAB was obtained by evaluating the
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mean |j and standard deviation o  of SpC>2 over an interval prior to the apnea 
event, PAB =p-2a. The interval was chosen to be within 120 seconds of the 
beginning of the VLA, but not containing another desaturation with an area 
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Figure 16: Methods for measuring severity o f apneas, (a) For each signal, a baseline is 
chosen. For heart rate the mean minus two standard deviations in an interval before the 
apnea that contains no significant deceleration is chosen as a baseline. For SpC>2 the 
lower of a similar baseline or 92% is used. The areas between the chosen baseline and 
the signal are computed. In this case the VLA is followed by short events, and after 
reaching a minimum, SpC>2 rises and falls again. We include only the area up to the 
marked boundary, at the local max of SpC>2. (b) Heartbeat deficit (HR) vs. apnea 
duration for one infant, with linear fits using the least squares method, (b) Oxygen deficit 
(O2) vs. apnea duration. Linear fits and correlation coefficients are given in Table 4. 
(Reproduced from Mohr et al. 2015b.)
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22 %-minutes. The second threshold was chosen to be 80%, the desaturation 
threshold in our ABD definition.
We choose to limit the impact of confounding variables by carrying out 
these measurements on data from one patient. We chose the patient who had 
the largest number of long apnea events. Random sets of ABD10-20 and 
ABD30-40 events from this infant were collected and the measurements were 
made on both long and short apnea events. The results of these measurements 
are shown in Figure 16b. The 80% threshold gives a slope that is about half of 
the slope for the first threshold, but in both cases the correlation coefficients are 
comparable (see Table 4).
Table 4. Fits and correlation coefficients between Duration (T) and Area (A)_____
Linear fit Correlation Coefficient
Oxygen, 1st threshold A = 0.31T - 3.0 0.81
Oxygen, 2nd threshold A = 0.17T - 2.58 0.75
Heartbeats, 1st threshold A = 0.66T+ 13.08 0.82
Heartbeats, 2nd threshold A = -0.0053T + 3.65 -0.04
The depth and duration of an associated bradycardia are relevant 
measures of the severity of an apnea event, but again, an area measure is more 
appropriate. For each event, a baseline was chosen from the heart rate prior to 
the apnea. Again, two different thresholds were chosen and the results were 
compared. The first threshold is the mean minus two standard deviations over an 
interval within 120 seconds from the cessation of breathing, but not containing a 
drop of more than 10 beats per minute. The area between that baseline and the 
actual heart rate while the heart rate is below the baseline was calculated. This
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area is the heartbeat deficit -  the number of heartbeats that the infant would 
have had if its heart rate continued at the baseline value minus the actual 
number of beats. In Figure 16a this baseline is shown and the area below the 
baseline in this case amounts to a deficit of 85 beats. The second threshold was 
chosen to be 100bpm (the bradycardia threshold in our ABD definition).
The results of these measurements can be seen in Figure 16c. In this 
case there is a marked difference between the results from the two different 
thresholds. The 100bpm threshold shows no difference between long and short 
apnea events. This result is consistent with our observation that NICU personnel 
respond quickly to bradycardia alarms. In contrast the first threshold shows a 
greater heartbeat deficit in longer apnea events.
The graphs in Figures 16b and 16c show measures of the relative 
significance of VLAs vs. short apnea events. The roughly linear trend suggests 
that a 90 second apnea results in about three times the oxygen deficit and three 
times the heartbeat deficit of a 30 second apnea. (This fact is not obvious a 
priori, because heart rate and oxygen saturation decrease slowly in long apnea 
events.) Such deficits could be reduced by earlier and more accurate 
identification of apnea events.
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Oxygenation before VLAs
A possible reason for elevated oxygen saturation before a VLA is that 
infants are breathing more rapidly before a VLA than they are before a short 
apnea.
The respiration rate reported by monitors is notoriously unreliable because 
of artifacts in the Cl signal. Our filtered Cl, from which most artifacts have been 
removed, was used to locate zero-crossings of the filtered Cl, and maxima and 
minima between each zero-crossing. Breath length was defined as the time 
between two successive minima. To prevent residual fluctuations around zero to 
be mistakenly interpreted as breaths, two additional criteria were applied: The 
probability of apnea was required to be less than 0.5 at the times of the minima 
and consecutive maxima and minima had to be at least 0.1 times the standard 
deviation of the signal.
Apnea events in VLA infants were examined. The respiration rate for 100 
breaths preceding each of the 86 VLAs, and also for 100 breaths preceding 100 
randomly selected apnea events of duration 10-20 seconds in the same infants 
were obtained. The breath durations leading up to a VLA are generally shorter 
than those leading up to a 10-20 second apnea. The median Sp02 also rises 
gradually in the 5 minutes leading up to a VLA.
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A mathematical model for the rate of decline of Sp02
Presented here is the theory represented by the theoretical curves in 
Figure 15 showing oxygen saturation as a function of time. The most striking fact 
about VLAs is that oxygen saturation falls more slowly in these events than in 
shorter apnea events (Figure 15). Why is this? We propose that the explanation 
of the slow fall of oxygen saturation is that both arterial and venous oxygenation 
are unusually high at the start of the event. The high value of venous saturation, 
Sv, causes the partial pressure of oxygen in the alveoli to drop rather slowly.
(The alveoli are the air sacs in the lungs where gas exchange takes place.) The 
high initial values of oxygen saturation correspond to values at which the oxygen 
dissociation curve (which gives the oxygen saturation as a function of the partial 
pressure of oxygen and is determined by the dissociation constants for oxygen 
and hemoglobin) is flat, a small change in oxygen saturation is a large change in 
partial pressure. As oxygen is absorbed from alveoli into blood, and the partial 
pressure of oxygen in the alveoli falls, the associated drop in arterial oxygen 
saturation is small. The following quantitative model shows this effect.
An excellent study of the theory of arterial oxygen desaturation during 
apnea in preterm infants was carried out by Sands et al. (Sands et al. 2009), 
following a long train of similar studies. This is the basis for the following theory 
which we compare with our observations. In Chapter 4 this model will be 
expanded to give a description of periodic breathing. The following assumptions 
and approximations are used: (1) Applying the principles of conservation of
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matter we find that during an apnea the only loss of oxygen in the lungs arises 
from diffusion into the blood. In the tissues oxygen is received from the blood and 
consumed by the metabolism. (2) In each heartbeat, gaseous oxygen in the 
alveoli equilibrates with oxygen in pulmonary capillaries so that the oxygen in the 
alveolar air is in equilibrium with the oxygen in the arteries. (3) Venous blood is 
homogeneous, with uniform SpC>2. (4) The oxygen saturation in the pulmonary 
vein leaving the lungs is equal to the oxygen saturation measured by the pulse 
oximeter a few seconds later, in the hand or foot. (5) All oxygen in the blood is 
carried by hemoglobin. (6) During the apnea, the cardiac output does not change 
significantly. This is a reasonable assumption because of the Frank-Starling 
mechanism whereby the heart contracts with greater force when it is stretched 
more during filling (Hall, Guyton 2011). (7) Sp02 is related to partial pressure of 
oxygen in the alveoli. In this model we use an equation first given by Hill (Hill 
1910) and quoted (with a slight change) by Delivoria-Papadopoulos and 
McGowan (Delivoria-Papadopoulos, McGowan 2011) to describe this 
relationship
Sp02 = 100&/^2 / ( 1 + )  (2.1)
In this equation, we took n = 2.9 (Delivoria-Papadopoulos, McGowan 
2011), and calculated k from reasonable values of P50, the value of pressure at 
which SpC>2= 50%.
In this model we are assuming that all oxygen in the blood is carried by 
the hemoglobin. (In chapter 4 we will not make this assumption.) The
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concentration of oxygen in the blood, C02, depends on the amount of oxygen that 
is bound to the hemoglobin and the amount that is dissolved in the blood plasma. 
Each molecule of hemoglobin has four binding sites for oxygen and at 100% 
saturation each gram of hemoglobin carries 1.36 ml of oxygen. The concentration 
of oxygen in the blood is given by C02 = \36Hb-Sp02 + 0.00003 \PQ2, where Hb is
the number of grams of hemoglobin per ml of blood and P0 2  is the partial 
pressure of oxygen in the blood. The second term is negligible and in this chapter 
we ignore it, thus we have C02 = \36Hb-Sp02.
By applying conservation of matter we find that in the lungs the amount of 
oxygen coming in equals the rate of blood flow, Q, times the concentration in the 
veins, Cv. (The veins are assumed to be in equilibrium with the pulmonary 
arteries.) The amount of oxygen leaving the lungs equals the rate of blood flow 
times the concentration in the arteries, Ca. (The arteries are assumed to be in 
equilibrium with the pulmonary veins.) The rate of change of oxygen in the lungs 
is the rate of change of the fraction of oxygen in the lung air, FA, times the volume 
of air in the lungs. In the tissues the rate of change of oxygen is the rate of 
change of the concentration of oxygen in the blood times the volume of blood in 
the tissues. The amount of oxygen coming into the tissues equals the rate of 
blood flow times the concentration in the arteries. The amount of oxygen leaving 
the tissues equals the amount of oxygen being consumed metabolically, MR02, 
plus the rate of blood flow times the concentration in the veins. (Figures 25 and
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26 in chapter 4 show the lung compartment and the tissue compartment in the 
expanded model.)
The equation for the rate of change of oxygen in the lungs is:
dF^ V L=Q(Cv~Ca) 
at
The fraction of oxygen in the lung air is proportional to the partial pressure 
of oxygen in the lung air, Pa, (according to assumption 2 the oxygen in the 
alveolar air is in equilibrium with the oxygen in the arteries).
dPa 1.36 HbQ(Sv- S a)
 OC ----------------------------------------   —
dt VL
where we used CQ2 =  1.36Hb • Sp02 to convert concentrations to oxygen 
saturation in the arteries, Sa, and oxygen saturation in the veins, Sv.
Changing from a rate of change of partial pressure to a rate of change of
, .. dPa dP dS .d S a dSa \M H bQ {Sv- S a)saturation using —-  = —- — -  we get — -  «  —  --------- —̂ — .
dt dSa dt dt dPa VL
dSa _ dSa \36HbQ(Sv—Sa)
which we write as
dt dPa VL
= D(Sa )C ■ (Sv(t) -  Sa (0) (2.2)
dt
where C is a constant which is proportional to ^  and D(Sa) = ̂ - .  The value
VL dPa
of D(5a) can be obtained from equation 2.1
The equation for the rate of change of oxygen in the tissues is:
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~^~V, = Q(Ca( t - T a) - C v) — MR02
where we have introduced the arterial transit time Ta, which is the time it takes 
the blood to go from the lungs to the tissues.
Using C02 =  1.36Hb • Sp02 to convert concentrations to oxygen saturations we 
have
Equation 2.2 is equivalent to equation 10 of Sands et al. (Sands et al. 2009), and 
equation 2.3 can be derived from equation 6 in Sands et al. Sa(t) is the oxygen 
saturation leaving the lungs, which by assumption is equal to the oxygen 
saturation measured a few seconds later in the hand or foot. Sv is the venous 
oxygen saturation. C is a constant, proportional to hemoglobin concentration in 
the blood and to the cardiac output, which is the rate of blood flow Q, and 
inversely proportional to lung volume, VL. Ta is the arterial transit time, d is equal 
to cardiac output divided by venous blood volume, and e is the rate at which 
oxygen is utilized by the tissues. We treat C,Ta, d, and e as constants, 
independent of time, and independent of the duration of the apnea event. From
Vt =Q(Sa(t-T a) -S v)-M R 02
at
which we write as
(2.3)
where e and d are constants and e = ancj d =  — .
V Vr  t  t
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their values, and from the initial conditions Sa(t = 0) and Sv(t =  0), the above 
equations determine the evolution of Sa(t).
These four constants and the initial conditions were determined by first 
obtaining preliminary estimates and then refining by fitting to the observations. 
The preliminary estimates were obtained by the following process. Sands et al. 
(Sands et al. 2009) showed that oxygen saturation during an apnea frequently 
follows a two-stage pattern. In the first stage (t <T) 5a(t) drops rapidly, while in 
the second stage, it drops more slowly and at a constant rate (Figure 17). In 
cases where the two stages can be easily identified on a graph of Sa(t), the 
arterial transit time T can be determined from the graph. Also, in the first stage 
S„(t) is constant. Hence in this stage, equation 2.2 contains two unknowns: Sv 
and C. These can be determined by choosing two points in time early in the
apnea, tj  = ( ta, t 2), extracting S(t7) and dS„
dt
from the observations, and then
solving the two equations for C and Sv.
To obtain estimates of d and e we set t  = Ta in equation 2.3 and find
c /(5 a(0 )-5 v(ra) ) -e  = J ( 5 a(0 )-5 v(0 ))-e  = 0 (2.4)
In the second stage, the arterial oxygen saturation falls linearly with time at a rate 
approximately equal to (Sands et al. 2009)
dSa(t) -e  
dt 1 + d T
(2 .5 )
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From the observed rate of decline in the second stage, and with 5 „(0)
dt
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Figure 17: An example o f oxygen saturation falling in two stages. SpO2 (measured in the 
arteries, SJ filtered Cl, and the probability o f apnea are shown. (Reproduced from Mohr 
et al. 2015b.)
Two issues remain. (1) There is a time delay between oxygen leaving the 
lungs and oxygen detected in the hand or foot. Part of this time delay is related to 
circulation time of blood and part of it is related to the averaging time of the 
oxygen monitor. A time delay of 20 seconds was chosen for all of the average 
curves in Figure 15, and gave satisfactory results. (2) The average saturation 
curves do not show any clear division between stage 1 and stage 2. Therefore, 
individual apnea events that show this distinction were used to obtain estimates 
of Ta, d, and e. There are several such cases, one of which is shown in Figure 
17.
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Finally, the values of these parameters were adjusted to fit the 
observations.
It is important to note that we used the same constant values of C, Ta, d, 
and e for short and long apnea events. We adjusted only the initial conditions 
Sa(0) and Sv(0) to fit the individual curves.
Table 5 lists the constants (except e, which can be found using equation 
2.4) and the initial conditions. The resulting theoretical curves are shown in 
Figure 15. The agreement with the average Sp02 curves is remarkable: over the 
whole of each of the ranges where SpC>2 is falling, the theoretical curves are only 
barely discernible from the observed ones, and differ from them by less than the 
standard error of the means of the observations.
Table 5. Initial conditions and constants
(uncertainty values in parenthesis were obtained by adjusting the parameters one at a 
time) (Reproduced from Mohr et al. 2015b.)____________________________
parameter ABD 10-20 ABD 30-40 ABD 60-80 (VLAs) ABD 80 (VLAs)
Sa 0.870 (0.005) 0.915 (0.007) 0.950 (0.005) 0.970 (0.003)




In parentheses in Table 5 we report the uncertainty in the values of the 
parameters. These were obtained by finding the standard deviation of the mean 
of each set of observations, and adjusting parameters one at a time to find
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values where the theoretical curves would disagree with observations by more 
than one standard error of the mean.
The theory given by Sands et al. (Sands et al. 2009) leads to remarkable 
agreement with our observations. It provides a credible explanation of why 
Sp02(t) falls slowly in long apnea events. Two factors are at work. At high oxygen 
saturations, the curve relating oxygen saturation to partial pressure of oxygen 
Sp02(P0i) is flat, and the function D(S) is near zero. In the alveoli and in the
arteries, a large change in partial pressure of oxygen gives only a small change 
in Sp02. As a result, Sp02 falls very slowly near the beginning of an apnea when 
oxygen saturation is high, in this regard the slow fall of Sp02 from high levels is a 
natural consequence of well-known physiology. The second factor is the inferred 
somewhat elevated oxygen saturation in the veins. We have no direct 
measurements of venous oxygen saturation, it is obtained only by fitting to the 
observations. However this is consistent with the rise of Sp02 in the 5 minutes 
prior to VLAs.
To understand the limits of the theory (Sands et al. 2009) as we apply it, 
let us re-examine some of the approximations. During an apnea, C02 
concentration and pH of the blood may change, and these shift the hemoglobin 
saturation curve, Sp02(P0i) .  This shift can be characterized by a changed value
of P50, the pressure at which hemoglobin is 50% saturated. This change, 
however, turns out to have only a small effect on the time dependence Sp02(t). 
One can include the effect approximately by changing the value of k in equation
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2.1 for the time before Sv changes. However, when calculating Sp02(t) as 
described above using equations 2.1 and 2.2, the value of k exactly cancels (for 
fixed C and Sv), so at this level of approximation, P50 has no effect. (In a more 
accurate treatment, again holding c and Sv fixed, P50 would have a nonzero but 
small effect; Sands et al. (Sands et al. 2009), who used the Severinghaus 
formula (Severinghaus 1979) instead of equation 2.1, found that a change of P50 
by 6-12 mmHg gave significant changes to Sp02(t), but part of the change they 
obtained resulted from changed initial values of Sp02 and Sv.)
Another effect we neglected is extrapulmonary right-to-left shunt (blood 
which does not get oxygenated in the lungs as it travels from the right heart to 
the left heart). Since we find that the median oxygen saturation before a VLA is 
96-98%, it appears that shunted blood is a small fraction of arterial blood, and 
would have little effect on the calculation of Sp02(t). Sands et al. (Sands et al. 
2009) also note that shunt fraction affects the starting value of Sp02(t) but has 
little effect on its rate of change.
Cardiac output was assumed to be approximately constant. This 
approximation is commonly used in models of short apnea events and models of 
periodic breathing (Khoo et al. 1982, Milhorn, Guyton 1965, Tehrani 1997), and it 
can be justified as a manifestation of the Frank-Starling mechanism (Hall, Guyton 
2011), which is now known to be present in neonates (Anderson et al. 1998, 
Girling 1972, Kirkpatrick et al. 1976, Price 2011).
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Further study of assumption (3), that venous blood is well-mixed and 
homogeneously oxygenated, would be beneficial. This should be accurate in 
steady state, but it is not clear that it would hold during the rapid changes of 
oxygenation that occur during apnea.
This theoretical method might turn out to provide useful physiological 
information. C and d are both proportional to cardiac output, e is proportional to 
metabolic rate, and Sv is the venous oxygen saturation, none of which are 
continuously available in NICU monitoring. By fitting the time course of Sp02 in 
individual apnea events to the theory, it may be possible to get estimates of 
these parameters during each apnea.
Conclusion
While apnea is a normal developmental phenomenon in preterm infants, 
very long apnea is an important problem that may reflect or lead to adverse 
events or outcomes. These events are interesting from a physiologic perspective 
and important from a patient safety perspective.
We found that very long apnea events are not rare. We used stringent 
criteria to define a VLA. We found that infants show no evidence of breathing for 
durations of up to 132 seconds. These events occur with a frequency of 1 per 70 
infant-days in our population.
We also found that VLA infants differ from non-VLA infants in that they 
have a much higher rate of short apnea events and presumably have less
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developed respiratory control. We found short apnea events in VLA infants to be 
indistinguishable from short apnea events in non-VLA infants.
It is difficult to establish the effect of VLAs on the short-term or long-term 
health of infants. Despite the slow drop of Sp02 in VLAs, the available measure 
of deficit in oxygen transport is approximately proportional to the duration of the 
cessation of breathing, i.e. 90 second apnea events result in approximately 3 
times the oxygen transport deficit of 30 second apnea events. Our information on 
clinical consequences leads to ambiguous results. On one end of the VLA 
spectrum, an apparently healthy preterm infant had 19 events over a 3 week 
period, and eventually died following a respiratory arrest from which he could not 
be resuscitated. However, other VLA infants had normal courses in the NICU. 
Lacking post-discharge objective neurodevelopmental follow-up testing on 
infants, we can only say that, with the possible exception of the infant who died, 
no clinical consequences could be proved to be caused by VLAs. Nevertheless, 
VLAs cannot be good for infants, and their frequency is disturbing.
Part of the explanation of why VLAs occur is that apnea alarms fail to 
activate in about one-third of these events. In addition, we previously showed 
that about two-thirds of all apnea alarms are false alarms (Lee et al. 2012), so 
alarm fatigue or alarm distrust may also be a factor (Vergales et al. 2014).
Clinical experience and our data suggest that bedside caregivers respond quickly 
to bradycardia alarms, which are “crisis” alarms on the monitors in the UVa NICU 
(in contrast to apnea “warning” alarms), but as a result of the slow fall of heart
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rate these alarms are delayed. We believe that more reliable apnea alarms, with 
fewer false negatives and false positives, would be helpful to NICU personnel 
and might have a significant beneficial effect on the health of infants by reducing 
hypoxemia and bradycardia.
The respiration rate was found to be somewhat elevated and Sp02 to 
gradually rise in the 5 minutes prior to a VLA. Accordingly, Sp02 is unusually 
high at the commencement of the event. Combining this observation with the 
hypothesis that venous oxygen is also somewhat elevated leads to a quantitative 
description of the average rate of fall of Sp02 with time.
Prolonged apnea events should be preventable. Since these events could 
have detrimental consequences and are often not noticed and/or not recorded in 
the medical record, improvements in bedside monitor apnea detection, alarm 




Wavelet Detection of Periodic Breathing
Periodic breathing, characterized by regular, repeated cycles of apneic 
pauses and breathing, has generally been considered to be a normal respiratory 
pattern in most if not all newborn infants (Rigatto 2003). However, several 
decades ago, excessive amounts of periodic breathing were observed in infants 
who had “near-miss sudden infant death syndrome” and in siblings of infants that 
died of sudden infant death syndrome (SIDS) (Kelly, Shannon 1979, Kelly et al. 
1980). A recent case of SIDS in a preterm infant discharged home from the 
University of Virginia (UVa) Neonatal Intensive Care Unit (NICU) led to an 
unexpected finding: on retrospective review of the UVa database, we found that 
this infant spent a strikingly large proportion of time in periodic breathing 
compared to other preterm infants, despite having almost no episodes of 
classical apnea of prematurity (AOP). To our knowledge this is the first time that 
excessive periodic breathing has been observed in a NICU patient who 
subsequently died of SIDS. Can such exaggerated periodic breathing be 
pathologic in newborn infants? To answer this question a new method of 
identifying and quantifying periodic breathing was developed.
The UVa dataset provides us with the ability to quantify periodic breathing 
on a larger scale than has previously been done. Here we describe a new
method of detecting periodic breathing. Our object is to use this method to
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calculate the amount of time that infants spend in periodic breathing. We seek to 
establish what normal amounts of periodic breathing are for infants based on 
gestational and postmenstrual age. These results are used to identify infants that 
had extreme amounts of periodic breathing. The clinical records of these infants 
are examined and clinical correlations with periodic breathing are sought to 
determine whether periodic breathing can give advanced warning of these 
conditions.
A widely accepted definition of periodic breathing has at least 3 cyclical 
apneas of at least 3 seconds duration with less than 20 seconds of breathing in 
between (Barrington, Finer 1990). As we will show, our detector recognizes such 
events, but we have reason to believe that this definition is too broad to provide a 
useful warning of impending pathology. First, we and others have observed that 
such brief episodes are very common, even in the absence of any indications of 
pathology. Second, physiological models of periodic breathing contain a natural 
distinction between transient oscillations and sustained oscillations. According to 
these models, periodic breathing represents high gain in the respiratory control 
system (Milhorn, Guyton 1965, Hall, Guyton 2011, Batzel, Tran 2000, Ben-Tal, 
Smith 2010, Cherniack, Longobardo & Evangelista 2005, Fowler, Kalamangalam 
2000, Khoo et al. 1982, Levine, Hathorn & Cleave 2004, Rapoport, Norman & 
Goldring 1993, Berger et al. 2000, Norman et al. 2006, Takahashi, Doi 1993, 
Tehrani 1997, Verma, Katiyar & Singh 2009). In neonates, high gain appears to 
result from hypersensitivity of the chemoreceptors that trigger breaths in
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response to changes in blood gases (Cherniack, Longobardo 2006, Al-Matary et 
al. 2004, Edwards, Sands & Berger 2013). Peripheral chemoreceptors are 
desensitized at birth, with the acute increase in blood oxygen content during fetal 
to neonatal transition, then are gradually reset by about one week of age at 
which time periodic breathing emerges (Barrington, Finer 1990). Hypersensitivity 
of chemoreceptors to changes in blood oxygen and carbon dioxide levels leads 
to self-sustained oscillations between breathing and apneic pauses, especially 
during quiet sleep (Pereira et al. 1995, Rigatto 2003).
In contrast to newborn infants, healthy adults rarely exhibit significant 
periodic breathing, except with acute exposure to hypoxia at high altitude 
(Ainslie, Lucas & Burgess 2013, Fowler, Kalamangalam 2002). Acute and 
chronic diseases can, however, lead to periodic breathing patterns such as 
Cheyne-Stokes respiration associated with heart failure (Dowell et al. 1971, 
Francis et al. 2000, Lange, Hecht 1962, Manisty et al. 2006, Vielle, Chauvet 
1993a, Vielle, Chauvet 1993b, Vielle, Chauvet 1998, Lieber, Mohsenin 1992). 
Cheyne-Stokes respiration is characterized by a regular pattern of respiration 
and apnea; the cycle time in adults ranges from 30 seconds to two minutes, and 
during the respiratory phase, both the amplitude and the frequency of breathing 
wax and wane in a regular crescendo-decrescendo pattern. Heart failure may 
cause excessive time delay in the control loop, which can also lead to high loop 
gain, resulting in periodic breathing. A similar pattern was seen in a small number 
of stroke patients (Hermann et al. 2007). A distinction between the patterns of
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neonatal periodic breathing and adult Cheyne-Stokes breathing is that the cycle 
time in the former has an average of about 15 seconds, while in the latter the 
average is about a minute. Both cases are apparently associated with high loop 
gain, but the physiological causes may be distinct: chemoreceptor 
hypersensitivity in infants vs. excessive time delay in heart failure.
There are several other types of abnormal respiration that are easily 
confused with periodic breathing, and the distinctions among them are not sharp. 
An excellent review is given by Richerson and Boron (Richerson, Boron 2005), 
who identify, besides Cheyne-Stokes respiration, Biot breathing, ataxic breathing, 
cluster breathing and gasping. During a study of Cheyne-Stokes respiration, Biot 
(Wijdicks 2007) came across a distinct pattern in patients with meningitis: there 
were irregular pauses lasting 10-30 seconds, and the breathing was irregular and 
rapid, without the crescendo-decrescendo pattern. Similar to Biot breathing are 
patterns called cluster breathing or ataxic respiration, which can occur as a result 
of lesions in the pons or medulla. It appears that there are not precisely defined 
differences among these.
Physiological models of periodic breathing involve a control system in 
which parameters have changed so that it has gone from a stable steady state to 
a stable limit cycle. For values of parameters between those leading to steady 
state and those leading to a limit cycle, one finds oscillatory decay to the steady 
state. In contrast, Biot breathing, cluster breathing, and ataxic breathing seem to 
involve more profound failure of the control system. To construct a pattern-
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recognition algorithm for periodic breathing, we focus not on the breathing, but on 
the apneas, and we ask whether the apnea events are occurring with a regular 
rhythm and, if so, is that rhythm sustained or does it stop after a short time?
Wavelet Detection
A wavelet transformation method was developed to identify and quantify 
periodic breathing. Two functions are used in the wavelet transformation: the 
wavelet and another function. The wavelet is shifted through the function and at 
every point the integral of the product of the two functions is taken, this gives the 
area overlap. Wavelets are designed with equal area above and below zero, thus 
the wavelet transformation with a constant function will give zero. The wavelet 
transformation begins with a mother wavelet, xp(t). From this mother wavelet a 
family of wavelets are calculated, t) = |s|-piK ~ )  (Kaiser 1994). These
wavelets have a size that depends on the scale, s, and a position that depends 
on the translation, t. Wavelet coefficients are calculated using y(s, t ) =  
SZof^^s.xi.Odt, where xj) is the complex conjugate of xp. (Our wavelet has no 
imaginary part so i/; = $.) These coefficients, y(s, t), are a function of time and 
scale. Wavelet coefficients calculated at lower scales give information about the 
finer details of the function. The term \s\~p in i/>S(X(t) is a scaling factor, p is 
commonly chosen to be either 0,1/2, or 1 (Kaiser 1994). We choose to set 
p = 1/2 as this choice leaves the maximum value of the wavelet coefficients 
unaffected by the scale.
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The wavelet transformation is uniquely suited to detect periodic breathing. 
Unlike the Fourier transformation, the wavelet transformation is localized, this 
means that the length of the signal segment that is being evaluated depends on 
the cycle length.
The Haar wavelet is a commonly used wavelet, developed by Alfred Haar 
in 1909. A wavelet transformation of the apnea signal using a Haar wavelet 
detects individual apnea events, but gives no additional information about 
periodicity of the apnea events. To detect periodicity it was necessary to use a 
wavelet that was itself periodic. Such wavelets already exist, but in this case it 
was advantageous to create a wavelet that was uniquely suited to its purpose.
Our previously developed probability of apnea signal (Lee et al. 2012) was 
used for periodic breathing detection. The unprocessed signal which contains 
apneic pauses as short as 2 seconds was used, after filtering out all times where 
the probability of apnea was non-zero due to a dropped signal.
Generous definitions of periodic breathing include as few as three apnea 
events (Barrington, Finer 1990). The appropriateness of such a definition can be 
debated. However, it may be beneficial to detect three repetitive apnea events 
even so. We then have the option of choosing a threshold value for the wavelet 
coefficient values that will exclude those short events when we choose not to 
consider them.
For periodic breathing detection a wavelet with six cycles was designed 
(Figure 18). This design allowed for detection of as few as three repeated apnea
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events. The wavelet was designed to resemble periodic breathing in the apnea 
signal, with six “apnea” phases and six “breathing” phases. There is a gradual 
transition between the breathing and apnea states. The wavelet is centered on 
zero and multiplied by a sine window. The gradual transition gives less weight to 
the signal at the transition time. Multiplication by the sine wave gives less weight 
to the beginning and end of the segment. (Three periodic apnea events give 
higher value than three events that are periodic but with a missing apnea 
between them). The wavelet was normalized so that the absolute value of the 
wavelet coefficient has a maximum value of 1 when the transformation of the 
apnea signal, which has a range of 0 to 1, is taken.
Figure 18: Mother wavelets and scaled wavelets for detecting periodic breathing. The 
two mother wavelets are modeled after the appearance of the probability o f apnea signal 
during periodic breathing, with multiplication by a sine window to weight the middle of 
the wavelet more heavily, a l) Mother wavelet with two phases (apnea and breathing) of 
equal duration. a2) Mother wavelet with one phase twice as long as the other, created to 
detect a wide range o f time ratios, bl, b2) Mother wavelets are scaled to different sizes 
(compressed or stretched along the horizontal axis), giving a family of wavelets that 
detect periodic breathing with cycle lengths ranging from 10-40 seconds. (Reproduced 
from Mohr et al. 2015a.)
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Two such mother wavelets were used. One had an apnea:breathing ratio 
of 1:1, the other had an apnea:breathing ratio of 2:1. Because we use the 
absolute value of the wavelet coefficients, an apnea:breathing ratio of 2:1 gives 
the same results as using an apnea:breathing ratio of 1:2. These two wavelets 
allow for the detection of periodic breathing with duty cycles of 1:4 to 4:1 (Figure 
19). (Giving less weight to the transition time improves the detection of periodic 
breathing at all ratios in this range.) The value of the wavelet coefficients is 
highest when the ratio is the same as the ratio of either of the two mother 
wavelets. However, Figure 19 shows that so long as the periodicity is sufficiently 
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Figure 19: Wavelet coefficients at different apnea:breathing (A:B) ratios. Also shown is 
periodic breathing with an A:B ratio o f 1:6 and with an A:B ratio o f 3:1.
The two mother wavelets are used to calculate a family of wavelets
V>s,t(0 = lsr pV,(“ )- These wavelets have a cycle length (related to the scale s)
(Figure 18b) and a position (r). A wavelet coefficient, y(s,r), is calculated every 
quarter second as the wavelet is shifted through the apnea signal. The wavelet
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coefficient is highest at the positions where the wavelet is most closely aligned 
with the apnea signal. During a segment of periodic breathing as the wavelet is 
shifted through the apnea signal the wavelet coefficients rise and fall. For 
periodic breathing detection we are only interested in the maximum values of the 
wavelet coefficients. The longest cycle length that we seek to detect is 40 
seconds. For this reason we choose to take the maximum value of the wavelet 
coefficients in a 40 second window across all scales. This is done every 20 
seconds. The result is our periodic breathing index. The periodic breathing index 
remains high during the entirety of the periodic breathing event.
The periodic breathing index is a continuous signal that is calculated 
throughout the entire apnea signal. To detect periodic breathing an appropriate 
threshold value is chosen. An episode of periodic breathing is defined as starting 
when the index first rises above the threshold and ending at the last point that is 
still above the threshold value. A higher threshold includes only the most periodic 
episodes of repeated apnea events. A lower threshold is useful when considering 
episodes of repeated apnea events that are less periodic. A preliminary analysis 
of the periodic breathing index suggested a threshold near 0.6 to distinguish 
periodic breathing. All times when this index was >0.6 were marked as periodic 
breathing events. After a threshold value is chosen the collection of periodic 
breathing episodes may be further refined by specifying that they last for a 
minimum length of time. When making these choices one should bear in mind 
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Figure 20: Wavelet transformation ofprobability of apnea signal to derive wavelet 
coefficients and periodic breathing index, a and b) 500 second window of the probability 
of apnea signal in a preterm infant, with shifted wavelet. At quarter second intervals, a 
wavelet coefficient is calculated that corresponds to the convolution o f the wavelet and 
the probability o f apnea signal. The absolute values o f the coefficients range from 0 to 1 
with a higher value indicating better alignment. Periodic breathing is identified when the 
coefficient meets or exceeds the threshold value of 0.6. In (a), the oscillations in the 
wavelet match those of the signal, giving a large wavelet coefficient, while in (b), the 
oscillations are out of phase, and the coefficient is small. Thus the coefficients oscillate 
rapidly as the wavelet is translated through the signal, c) Wavelet coefficients for scales 
corresponding to cycle lengths from 10 to 20 seconds. Lighter shades indicate higher 
values, d) The maximum of the absolute values o f the wavelet coefficients across all 
scales at each point is shown along with the periodic breathing index, which is the 




periodic breathing episode being split up into multiple shorter episodes due to 
slight dips in the periodic breathing index that drop below the higher threshold 
value.
Validation
For validation of the periodic breathing detection algorithm 200 four minute 
windows of raw and filtered chest impedance, EKG, heart rate, oxygen 
saturation, and apnea signal data centered on an ABD10 tag were collected. 100 
windows were randomly chosen from the set of all four minute windows centered 
on an ABD10 tag where the periodic breathing index met the threshold value of 
0.6 at some point during the four minutes. The other 100 were randomly chosen 
from all four minute windows centered on an ABD10 tag where the periodic 
breathing index did not exceed 0.6 during the entire 4 minutes.
These 200 windows were examined by clinicians. They had no knowledge 
of how the windows were chosen. They were told to evaluate the windows and 
decide if they considered there to be any periodic breathing in the window. Four 
clinicians first reviewed the samples independently. All cases in which there was 
not 100% agreement were subjected to group discussion. Consensus was 
reached for 180 of the samples. These 180 samples were used to evaluate the 
reliability of the periodic breathing detection algorithm. The clinicians determined 
that 73 of the samples included periodic breathing and 107 did not, 20 were 
disputed. Based on this result we tested the predictive capability of a periodic
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breathing index >0.6 for detecting clinician-identified undisputed periodic 
breathing. The maximum values of the periodic breathing index in the four-minute 
windows were 0.74 ± 0.03 (mean ± 95% Cl) for 73 windows with clinician- 
identified undisputed periodic breathing, 0.40 ± 0.02 for 107 windows with no 
clinician-identified periodic breathing, and 0.66 ± 0.02 for the 20 disputed 
windows (Figure 21). Of the 73 windows that contained clinician-identified 
definite periodic breathing, the computer-derived periodic breathing index was > 
0.6 for 70 (96% sensitivity). Other diagnostic utility measures are shown in Table 
6. Calculation of the ROC curve (area under the curve = 0.98) showed that the
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maximum value of the PB index
Figure 21: Superimposed histograms of the maximum value o f the periodic breathing 
index (PB index) for the groups o f clinician-identified periodic breathing (clinician yes) 
and no clinician identified periodic breathing (clinician no). The windows are classified 
according to the maximum value o f the periodic breathing index in that window. The 
maximum periodic breathing index is at least as great as the value shown on the x-axis. 
(For example, there are 3 windows with a maximum periodic breathing index 39.1 and 
<0.2.) (Reproducedfrom Mohr et al. 2015a.)
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product of sensitivity and specificity was maximized at the threshold of 0.6, 
confirming the appropriateness of this value.
Table 6: Contingency table from validation of wavelet transform analysis
(Reproduced from Mohr et al. 2015a.)
Clinician
Yes No Total
Yes 70 11 81 positive predictive value 86%
No 3 96 99 negative predictive value 97%






Research on periodic breathing in infants has been limited, in part 
because this breathing pattern is transient and considered to be benign, and in 
part due to lack of methods to characterize and quantify periodic breathing in 
large numbers of infants over long periods of time. Our finding that a former 
NICU patient that died of SIDS had an inordinate amount of periodic breathing 
led to the development of an automated method to quantitate periodic breathing 
in all UVa NICU patients, a first step toward being able to quantify and 
characterize both normal and excessive, potentially pathologic periodic breathing 
in NICU patients.
An important feature of our wavelet method is its ability to distinguish 
irregular clusters of AOP from periodic breathing (Figure 22). Two questions
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were asked: (1) Are the apnea events brief and occurring with a regular rhythm? 
(2) Is this regular apnea/breathing rhythm sustained for at least 3 cycles? Making 
this distinction is important. While periodic breathing can be described by 
physiological models with a well-behaved control system, in which the system 
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Figure 22: Periodic breathing versus clustered apnea. Four-minute window of heart rate, 
oxygen saturation (Sp02), raw and filtered chest impedance (Cl), probability of apnea 
signal, and periodic breathing index. Periodic breathing is identified by the wavelet 
method when the periodic breathing index meets or exceeds the threshold value o f0.600. 
a) Regular, repetitive apnea/breathing oscillations (maximum wavelet coefficient=0.905) 
identifying true periodic breathing, b) Cluster of irregular apnea/breathing. The 
computer did not identify this as definite periodic breathing since the wavelet coefficient 
was always below the threshold value (maximum wavelet coefficients.598). 
(Reproduced from Mohr et al. 2015a.)
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(periodic breathing) (Cherniack, Longobardo 2006, Khoo et al. 1982), entirely 
different mechanisms may be responsible for clustered apnea. AOP and periodic 
breathing are distinct in character, gestational age predilection, and timing of 
onset and resolution (Barrington, Finer 1990). AOP is uncommon in infants >34 
weeks’ gestation, whereas periodic breathing is very common in both late 
preterm and term infants (Glotzbach et al. 1989, Oliveira et al. 2004). AOP 
begins within 1 -2 days after birth and usually resolves between 36 and 42 weeks 
postmenstrual age (Eichenwald, Aina & Stark 1997), whereas periodic breathing 
typically starts after the first week and often persists beyond NICU discharge, for 
up to several months past term-corrected age (Wilkinson et al. 1995). The timing 
of onset of periodic breathing coincides with the time that peripheral arterial 
chemoreceptors, silenced at birth with the acute rise in blood oxygen levels, 
become highly sensitive to small fluctuations in blood gases (Pereira et al. 1995, 
Khan et al. 2005).
Periodic breathing typically includes apneic pauses of less than 10 
seconds and may entrain only small or no decline in heart rate and oxygen 
saturation (Poets, Southall 1991, Razi, DeLauter & Pandit 2002), rarely low 
enough to reach the threshold to trigger bedside monitor alarms, whereas AOP is 
often prolonged and associated with significant bradycardia and oxygen 
desaturation (Finer et al. 2006). Hypoxia may trigger or exacerbate AOP or 
periodic breathing (Al-Matary et al. 2004), and administering oxygen to preterm 
infants can minimize both (Weintraub et al. 1992, Simakajornboon et al. 2002).
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Advantages of the method
Past studies of periodic breathing have been limited to short monitoring 
times in small numbers of infants, often with visual inspection of respiratory 
impedance or inductance waveforms for characteristic apnea/breathing cycles. 
Our automated apnea algorithm gives a reliable measure of central apneic 
pauses, which can be used to quantify periodic breathing in large numbers of 
patients over long periods of time. This wavelet method distinguishes periodic 
breathing from apnea clusters where the durations of apnea and breathing are 
irregular. With increasing availability of high-speed data processing it is likely that 
this method could ultimately be applied in near-real-time to assess for immature 
breathing patterns that may have important clinical implications.
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Chapter 4
A Model of Periodic Breathing
Mathematical models of periodic breathing give a quantitative description 
of the respiratory control system. Such models have been used to show under 
what conditions breathing is stable and regular, and under what conditions the 
respiratory control system goes into oscillations, representing periodic breathing. 
We would like to connect these models to properties that are measured and 
observed in the NICU. These properties include: respiration rate, depth of 
respiration, phase of breathing, oxygen saturation, and heart rate. Our studies 
have shown that periodic breathing can increase during times of illness, as 
discussed in chapter 5. We would like to use periodic breathing models to 
discover how and what physiological parameters are changed during illnesses 
where periodic breathing increases. We would also like to show how parameters 
change in healthy infants when they experience periodic breathing.
Previous models of periodic breathing have described the respiratory 
control system and shown the conditions under which breathing is stable and 
also the conditions for instability. These models start with simple principles and 
well established facts from which a set of differential equations are derived which 
model the respiratory control system. In 1954 Grodins et al. applied methods of 
control theory to the respiratory system’s regulation of carbon dioxide (Grodins et
al. 1954). This paper gave rise to a number of others on the chemical control of
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respiration. Periodic breathing was seen in models which described carbon 
dioxide regulation only under unrealistic conditions. However, when oxygen 
regulation was included, periodic breathing was seen under more realistic 
conditions. As the complexity of these models increased, they were more helpful 
in understanding the causes of periodic breathing (Carley, Shannon 1988, 
Edwards, Sands & Berger 2013, Cherniack, Longobardo 2006, Batzel, Tran 
2000, Levine, Hathorn & Cleave 2004, Norman et al. 2006, Rapoport, Norman & 
Goldring 1993, Takahashi, Doi 1993, Tehrani 1997). In 1982 Khoo et al. 
introduced a model which analyzed the stability of the respiratory system in 
adults (Khoo et al. 1982). This model is the basis for the one we give here with 
modifications for infants based on the work of Batzel and Tran (Batzel, Tran 
2000).
The set of differential equations in periodic breathing models have a 
steady state which represents steady breathing. When parameter values change 
the system can go from a stable steady state to a stable limit cycle. Linearizing 
the equations about this steady state shows whether it is stable or unstable. The 
unstable case can lead to oscillations. Exact solutions to the differential 
equations show the transition from steady state to oscillations.
We present here a mathematical model of periodic breathing in infants. 
Stability analysis is applied to show that infants are more susceptible to periodic 
breathing during sleep. We also show that high controller gain, increased arterial
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oxygen, decreased arterial carbon dioxide, and decreased lung storage volume 
for oxygen increase the infant’s susceptibility.
This model contains many parameters that can be estimated from known 
values for infants, but these values are not measured for individual infants in the 
NICU, therefore we are unable to directly connect these parameters to 
observations.
We would like to use this model of periodic breathing to study the effect 
that illness has on periodic breathing. However, essentially no information is 
available about the effect of pathogens, or the immune response to them, on the 
parameters which govern the transition of the respiratory control system to 
oscillations.
Essential concepts
The model of periodic breathing presented here includes peripheral 
chemoreceptors for carbon dioxide and oxygen and central chemoreceptors for 
carbon dioxide. There is one lung compartment, one body tissue compartment, 
and one brain tissue compartment. We assume constant temperature, pressure, 
and humidity in well-mixed (homogenous) compartments. We neglect 
extrapulmonary right-to-left shunt, as we did in chapter 2.
The central and peripheral chemoreceptors regulate breathing. The 
oxygen and carbon dioxide peripheral chemoreceptors are located mainly in the 
carotid bodies in the bifurcations of the common carotid arteries (in the neck),
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some are also located in the aortic bodies in the aortic arch (just above the heart) 
(Hall, Guyton 2011). The central carbon dioxide receptors are located in the 
medulla oblongata (in the brain). The central chemoreceptors regulate carbon 
dioxide, while the peripheral chemoreceptors respond mainly to oxygen but also 
to carbon dioxide. The peripheral chemoreceptors have a quicker, but less 
powerful response than the central chemoreceptors. In general it is the central 
receptors that are responsible for the long term response while the peripheral 
receptors are mainly responsible for periodic breathing.
In chapter 2 we presented a list of assumptions and approximations from 
which we derived a model of oxygen desaturation. Here we modify that list to 
extend the model to apply to periodic breathing. The following principles and 
approximations are used to derive the periodic breathing model (Figure 23): (1) 
Matter is conserved. The oxygen entering the body during inhalation equals the 
amount exiting during exhalation plus the amount that is consumed metabolically. 
Similarly for carbon dioxide. (2) The blood that passes through the pulmonary 
capillaries in the lungs comes to equilibrium with the alveolar gas. Therefore the 
arterial blood is in equilibrium with the alveolar gas. Also, the partial pressures of 
oxygen and carbon dioxide in the body tissues are in equilibrium with the partial 
pressures in the veins. (3) The peripheral detectors are in direct contact with the 
arterial blood and measure the partial pressures of oxygen and carbon dioxide in 
the arterial blood where they are located. The central chemoreceptors are not in 
direct contact with the arterial blood and measure the partial pressure of carbon
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dioxide which arrives at their location after a diffusion process. (4) The
respiratory controller integrates information from the central and peripheral
chemoreceptors and adjusts the ventilation rate towards steady state
accordingly. (5) There are time delays in the system which can destabilize the
system. The blood at the body tissues and the chemoreceptors is the blood
Table 7: Symbols used in the periodic breathing model
Ca (CaCo2, Q 02) = arterial concentration (ml o f gas/ml of blood)
Cv (Cyco2, Cv02) = venous concentration (ml o f gas/ml of blood)
Cbvco2 = venous concentration of C0 2  in brain (ml o f gas/ml of blood)
Fa = alveolar mole fraction
Fi = inspired mole fraction
Gc = central control gain (liters/min/mmHg)
Gp = peripheral control gain (liters/min/mmHg)
Hb = hemoglobin content (grams of hemoglobin/ml of blood)
Ic = central apneic threshold (mmHg)
I p = peripheral apneic threshold (mmHg)
Pa (Paco2, Pao2) ~ arterial blood partial pressure (mmHg)
Pi (P1C02, P102) = partial pressure of inspired air (mmHg)
Pbco2 = partial pressure of C02 in brain (mmHg)
MR (MRco2, MR02) = metabolic rate of CO2 production/0 2  consumption (liters of 
gas/second)
MRbco2 = metabolic rate of C02 production in brain (liters of gas/second)
Q = cardiac output (liters o f blood/second)
Qb = cerebral blood flow (liters o f blood/second)
S = oxygen saturation
VA = total lung volume (liters o f gas)
VA = alveolar ventilation (liters of gas/second)
VD = dead space ventilation (liters of gas/second)
VE = minute ventilation (liters of gas/second)
Vl (Vlco2, Vlo2) -  effective lung volume (liters of gas)
Vt (Vtco2, V,02) = total tissue volume (liters of gas)
VT (Vtco2, VTo2) = effective tissue volume (liters of gas)
Vb = total brain volume (liters of gas)
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which was in the lungs at an earlier time and has the properties of the blood in 
the lungs at that earlier time. The blood returning to the lungs was in the body 
tissues at an earlier time.
In the periodic breathing model we do not neglect the oxygen that is 
dissolved in the blood plasma. Also, in the periodic breathing model we use a 
















body tissues < r
Figure 23: A model of periodic breathing
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Minute ventilation
Minute ventilation (VE) is the rate at which air is inspired. Not all the air
that is inspired makes it to the lungs. The air that remains in the respiratory 
passages is called dead space air (Hall, Guyton 2011). Alveolar ventilation is
equal to minute ventilation minus dead space ventilation VA =VE-VD.
Measuring oxygen and carbon dioxide in the body
The amount of carbon dioxide or oxygen in air is measured in terms of
partial pressure. Standard atmospheric pressure is 760 mmHg. The air that is
inhaled is humidified in the respiratory passages. The air that reaches the alveoli
in the lungs is completely humidified (Hall, Guyton 2011). Water vapor has a
partial pressure of 47mmHg at body temperature (310.15 K). If the glottis is open
the total pressure of air remains at 760 mmHg inside the body. Thus, the
humidification of the inhaled air dilutes all the gases in the air lowering their
partial pressures as shown in Table 8 (Batzel, Tran 2000, Hall, Guyton 2011).
Table 8: Values for partial pressures of gases in air and body used in model (for 4 
month old awake infant)______________ _____ ____________
Carbon
dioxide Oxygen Water vapor
Atmospheric air 0 mmHg 150 mmHg 3.7 mmHg
Humidified air 0 mmHg 141 mmHg 47 mmHg
Alveolar air 34 mmHg 96 mmHg 47 mmHg
Arteries 34 mmHg 96 mmHg -
Tissues 36 mmHg 48 mmHg -
Veins 36 mmHg 48 mmHg -
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How are carbon dioxide or oxygen measured blood? When we have a 
solution of liquid that is in equilibrium with air, the partial pressure of a gas in that 
air depends on the concentration of the gas in the solution. We say that the 
partial pressure of a gas in the solution is the partial pressure that we would see 
in air that is in equilibrium with the solution.
We can convert between concentrations of gases in the blood and partial 
pressures using dissociation curves which give the relationship between 
concentration and partial pressure. We assume that the values of the carbon 
dioxide dissociation curve are the same in infants as in adults (Batzel, Tran 
2000). The oxygen dissociation curve in infants shifts with maturation.
We assume that the dissociation curves are the same in all compartments.
The carbon dioxide dissociation curve is represented by the following 
linear equation:
Oo2 = ^CD2 ' ̂ ooa "*”^1002 
where =0.0065 and Kxan =0.244 (Khoo et al. 1982).
The oxygen dissociation curve was approximated by Severinghaus and 
further modified by Sands et al. for better accuracy
5  = — j  ----------p  3 + k P50 T  ' V  SO , 1
P 3 + k P1 0 2  T l l l ' 0 2
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9 p  3 — p  3
where kt = —- ----- — and Px  and P^ are the partial pressures of oxygen at 50%
9̂0 _ ̂ 5̂0
and 90% saturation respectively (Sands et al. 2009). The relationship between 
oxygen saturation and concentration is given by:
Cm =136Hb ■ S+0.00003\Pcn
One molecule of hemoglobin has four binding sites for oxygen. At 100% oxygen 
saturation each gram of hemoglobin carries 1.36 ml of oxygen, this gives the first 
term. The second, and much smaller, term comes from the amount of oxygen 
dissolved in the blood plasma.
Parameter values are given in Table 9 (Delivoria-Papadopoulos, Roncevic 
& Oski 1971). Figure 24 shows the dissociation curves that are calculated this 
way.
Table 9: Parameter values for oxygen dissociation
Px (mmHg) Pa (mmHg) Hb (g/ml)
Day One 19.4 42.5 0.178
Day Five 20.6 45.5 0.162
3 weeks 22.7 50.2 0 .120
6-9 weeks 24.4 53.5 0.105
3-4 months 26.5 58.5 0.102
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Figure 24: Calculated dissociation curves for oxygen
Development of the periodic breathing model
Equations for the lung, body tissue, and brain compartments are derived 
using conservation of mass. In the lungs the rate of change of oxygen or carbon 
dioxide is equal to the rate inhaled minus rate exhaled plus rate coming in from 
veins minus the rate leaving in arteries. The rate of oxygen or carbon dioxide 
inhaled or exhaled is equal to the alveolar ventilation rate VA times the fraction of
oxygen or carbon dioxide in the air, humidified air for inspiration, alveolar air for 
exhalation. The fraction we use is the mole fraction, the number of moles of 
oxygen or carbon dioxide per the total number of moles of air.
In the body tissues the rate of change of oxygen is equal to the rate in 
from the arteries minus the rate out through the veins minus the rate of metabolic
consumption of oxygen. The rate of change of carbon dioxide in the body tissues 
is equal to the rate in through the arteries minus the rate out through the veins 
plus the rate of metabolic production of carbon dioxide. The rate of oxygen 
coming in through the arteries is equal to the rate that the blood is being pumped, 
called cardiac output, times the concentration of oxygen in the blood. Similarly, 
for oxygen out through the veins and carbon dioxide in the arteries and veins.
The rate of change of carbon dioxide in the brain where the central 
chemoreceptors are located is equal to the rate of carbon dioxide in through the 
arteries minus the rate out through the veins plus the rate of metabolic production 
of carbon dioxide in the brain. The blood flow in the brain is smaller than the total 
blood flow in the arteries and veins. The rate of carbon dioxide in through the 
arteries is equal to the cerebral blood flow times the concentration of carbon 
dioxide in the arteries. The rate of carbon dioxide out through the veins is equal 
to the cerebral blood flow times the venous concentration of carbon dioxide in the 
brain. Note that while the concentration of carbon dioxide in the arteries of the 
brain is the same as the concentration in the arteries elsewhere, the 
concentration in the veins of the brain is not the same as the concentration in the 
veins elsewhere.
The respiratory controller uses the input received from the 
chemoreceptors to set the ventilation rate. Periodic breathing arises because of 
the delay in the time it takes blood from the lungs to reach the chemoreceptors. 
The controller responds to the amount of carbon dioxide and oxygen at the
78
chemoreceptors which was the amount at the lungs at some earlier time. During 
periodic breathing we see the controller responding to low carbon dioxide at the 
chemoreceptors, but by this time the carbon dioxide at the lungs has already 
returned to normal. This causes the system to overshoot and by the time the 
blood with a normal level of carbon dioxide has reached the chemoreceptors and 
the controller responds to it, the level of carbon dioxide at the lungs has already 
increased above the normal level. The peripheral control gain and the central 
control gain govern the intensity of the response to high or low levels of carbon 
dioxide or oxygen. The ventilatory response is proportional to the control gain 
times the difference between the detected partial pressure of carbon dioxide and 
the apneic threshold. If the partial pressure is higher than the apneic threshold 
the ventilatory response is positive, otherwise it is zero. Higher gains result in a 
greater change to the ventilation rate increasing the likelihood of periodic 
breathing.
Mathematical formulation of the periodic breathing model
F Pr n r i  
inspiration —
expiration
F P1 A* r a
V F PL ’ A 5 a
arteries
veins
Figure 25: Lung compartment 
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Conservation of mass gives the following equation for the lung
compartment (Figure 25):
-7T=Q (Cv- C a) + VA(F, -F a) 
at
(4.1)
Concentrations are defined as the effective volume of the gas divided by the total 
storage volume of the gas. Partial pressures and ventilation rates are typically 
measured at BTPS (body temperature and pressure, saturated with water vapor) 
while concentrations are measured at STPD (standard temperature and 
pressure, dry). Giving equation 4.1 with concentration in STPD and all other 
terms in BTPS introduces a conversion factor of (body temperature) / (standard 
temperature) = 310.15K / 273.15K.
Equation 4.1 now becomes:
(4.2)
To put equation 4.2 in terms of partial pressures we use
F, = - f  , where Pb is barometric pressure (760 mmHg), and
B
~ = - ^ - , the second equality gives
* a V i dt dt VL
Finally we have:
dPa _ ( Q(Cv- C a) ■S63mmHg + VAP,-P.) (4.3)
Equation 4.3 applies to both oxygen and carbon dioxide:
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dPa C O l Q ^ P v C O l  C a C O l  )
dt
vCQ2 ^ a 0 2 >  . m m H g  +  Y A 3.CQ2 J& C Q 2  ) (4.4)
L C O l LC 02
dPa O 2 _
dt
Q(C*o2 Cao2 ) .S63mmHg + V̂ P>o2 ^ 02) (4.5)
LO  2 L 0 2
arteries body tissue veins
M R ^ o i M R q i
Figure 26: Body tissue compartment
Applying conservation of mass to the body tissue compartment (Figure 26) gives:
dt
Using VT =  CyVt we have:
dVTĴ --Q (.C aC02- C vC02) + MRc02
dCvCQ2 _ Q(CaCQ2 ' QcQ2 ) . MRCq2.+22^col (4.6)
dt ÎC02 Kc02
Similarly, for oxygen we have:
h< r - r  \ u p
(4.7)dCv02 _ Q(Ca02 CyQ2 ) MRq2
dt V Vu i  r  tQ2 r  tQ2
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Figure 27: Brain compartment
Applying conservation of mass to the brain compartment (Figure 27) gives:
dCbycoi _ Qb{CaC01 CbvC02)  ̂ MRbcm
dt Vb Vb
Using the linear approximation of the carbon dioxide dissociation curve yields:
dPbcol _Qb(pCC02-P b C02) , MRbcm
dt Vb Kc m Vb
(4.8)
The response of the chemoreceptors takes the form:
V ^ G p e ^ i P ^ - I r )
V c ^ Q t fZ n - Ic )
(4.9)
(4.10)
where VE=VP+VC (Khooetal. 1982, Severinghaus, Crawford 1978, Rebuck, 
Slutsky & Mahutte 1977). A negative ventilatory response has no physiological 
meaning. If Gpe~005PaO2(F%:o2—Ip )< 0, then we say Vp = 0 , and if
~ Jc) < then we say Vc = 0.
82
It has been shown that the central controller responds to carbon dioxide in 
the brain compartment, Pbcm- We can rewrite equation 4.10 in terms of Pt>cm by 
using equation 4.8 at steady state.
  MRh^.
(4.11)P -  ph ^ 0 2
aC02 C°2 KcmQb 
vc = a c(Pbc02- ^ m - i c) (4.12)
Time delays
To account for the time it takes for the blood to travel through the arteries 
and veins, we put the time delays from Table 10 into our set of equations.
Table 10: Time delays
Xt lung to tissue delay 8 seconds
T v tissue to lung delay 9 seconds
Tb lung to brain delay 4 seconds
lung to peripheral receptors delay 3 seconds
With time delays our set of equations becomes:
dt
Va(P,co2 - P « » M ''
L C 0 2 L C O l
dPa02(t)
dt
f Q (cM2(i - k ) - cM2(D) 863mmHg +
V VL02 v LO1




V Vr  ICO 2 r  ICO 2







102 tO  2
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dPbcO l^t) _  Qbj^PqCOzit 7fe) PbyCOl^?)) J M R b CQ2 
dt Vb Kc02 ■ Vb
v. = Vc -V D=Gre m>'!°’ (p:co, - f r )+G c ( Pbco,(t)-?£££m : - l c) - V D (4.18)
 ̂ KcoiQb )
^aC02 = ̂ aC02 an<̂  ^aC02 =  ^aC02 (* ~  )
Running the model
When a disturbance is added to the system, equations 4.13 -  4.18 give 
the oscillatory behavior shown in figure 28. Although we included time delays in 
the periodic breathing model, we did not included the effects of the mixing of 
blood in the arteries and veins. The partial pressures and the ventilatory rate 
shown in figure 28 have a wide range. Including the effects of mixing would 
smooth out these oscillations and give a smaller. Furthermore, the measured 
Sp02 is an average over several seconds, so that would further reduce the 
















Figure 28: Equations 4.13 -  4.18 give the oscillatory behavior when a small disturbance 
is added. The disturbance that was added here lasted for the first five seconds. Although 
the minute ventilation is forced to be positive, the ventilatory drive, which was used in 
running the model, was allowed to be negative. The values used were for the asleep 2 
case given in table 12.
Linearizing the equations
Equations 4.13, 4.14, and 4.18 are nonlinear. To evaluate the model we 
linearize these equations using a Taylor series expansion. We can use the 
linearized equation to analyze the model analytically around a steady state. The 
linear equations give a good approximation as long as we stay close to the 
steady state. If we move too far away then our linearized equations will no longer 
apply.
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Using a Taylor series expansion to linearize equation 4.13 we get:
d P a C O l(0 _ { Q (CvC02(t K) CaC02(t))  LĴ  t• 863mmHg +
+ V PCQ2 ^  r  A r a
dt V,L C O lV
We have used the bar above a variable to represent the steady state value. 
Equation 4.14 becomes:
Loop gain and stability analysis
To evaluate the stability of our system we will introduce a small sinusoidal 
disturbance. This disturbance could represent an infant yawning or sighing, 
which could give rise to periodic breathing if the system is unstable. The ratio of 
the magnitude of the system’s response to this disturbance to the magnitude of 
the disturbance itself is the loop gain. Loop gain is a function of the frequency of 
the disturbance.
We use the Nyquist stability criterion to evaluate stability when a 
disturbance with a frequency <o is introduced. The Nyquist stability criterion gives 
two conditions which must be met for a system to be unstable: (1) The magnitude 
of the loop gain evaluated at the complex frequency io) is at least 1. (2) The polar







angle of the loop gain evaluated at ico is 180°. This angle is referred to as the 
phase lag.
To derive expressions for the loop gain and phase lag we apply a small 
perturbation such that the total response, x  ( t ) , equals a steady state term, ~x ,
plus the perturbation term, X(t). We then take the Laplace transforms of the 
resulting equations. We denote the Laplace transform of x ( t )  as jsr(s). The
Laplace transform ofX (t)= X (t)+ X  is = X (s) + -~X . (Recall that the Laplace
transform of is xY(5)-JT.) We replace Cv and Ca with K PV and K P a
dt





QK(PV-P a) 863mmHg +
$63mmHg Q K
At steady state equation 4.3 becomes , simplifying
dt T V,
gives:
P - P  = - V M z L l j
vL
(4.19)
Similarly for equations 4.6 and 4.7, letting Tr =-4-, we have:
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Taking the Laplace transform of equations 4.6 and 4.7 we have:
VKs
Note that sPv(s)-Pv=sPv(s)- Using equation 4.11:
P M  1
pa(s) 1 +  s Tt
(4.21)
We now turn our attention towards equation 4.3. We replace the term VAPa with a
Taylor expansion keeping only lower order terms, VAPa + VAPa -V APa . Then, taking
the Laplace transform we have:
sPa{s ) -J a
Further simplification gives:
Pa(s)T (  V  ^ s-1— -
ys r* /
Then we substitute using equations 4.19 and 4.21:
P .W




\  +  s Tt
VA(Pl -Pa)Tv i  yÂ
I s v,\  A J
V sTsT + L l t + J 1 jl-
VL 1 + sTt
-  ( w - p . y -P a(s) - (P i-P J r fVL (s)
Pg(s) (P,~Pa)T
yAs) „ V  sTsT + LLT + ̂ Ih -
VL 1 + 57r
The Laplace transform of equation 4.8 is:




with T b = and using equation 4.11:
s P b c 0 2 (s )  — j,fo{PaC0AS) ^ £ 7 0 2  C5)) ( ^ r C 0 2  P^C02)
sPbco2 (s) = j - ( P acC02(s) -  Pbco2 (5>)
PaC02(s) = {sTb + l)Pbc02(s)
We come now to the control equations. 
Equation 4.12 at steady state is:
vc =Gc{Pbcm- ^ m - i c)
XayiQb
thus:
j  —  p u  MRbC0 2 Vci r — ruco 2
P-coiQb Gc
taking the Laplace transform gives:








Vc(s) = Gc(Pbc02( s ) - ? ^ - ) + ^
s s
Vc(s) = Oc Pbco2(s)
’'c(,)=Cc|rrb» lf’-"=<s)
For equation 4.9 we let f 02 = e °mp°°2. Taking the Taylor expansion we get:
Vp = Vp -0.05G pf O2(PaCO2- I P)(P:o2-P a02) + GPf 02(P;C02- paC02) 
then the Laplace transform is:
VB
VF(s)= -Z -0 .0 5 G Ff o2(PM 2 - l F) +G Pfoi
s s
p P  aCQ2
r aC02\Af 
V 5 )
Vp{s) = -0.05 Gpf 02{PaC02- I P)P;o2(s) + GPf 02P;c02(s)
Let Vpc02(s) = GPf 02Pfc02(s) and Vp02(s) = -0.05Gpf O2(PaCO2- I p)Pfo2( s ) . Then
V £  —  V p  +  V c  — V p o 2 + y p C 0 2  +  y c
We have three gain terms; one due to the peripheral response to carbon dioxide, 
one due to the peripheral response to oxygen, and one due to the central 
response to carbon dioxide.
The peripheral response to carbon dioxide is: iG>c02 = ^J£2Z^-
%02(S) P*C02(S) VA(S)
. . .  . . r p(s) ^ ( s ) ^ ( s )The peripheral response to oxygen is: LGP02 =-===— -=£=?------— .
P ^ s )  Pao2(s) VA(S)
The central response to carbon dioxide is: LGC = ^002 fo)
FSxnis) Paco2(s) VA(S)
Our model includes time delay terms. These terms have a magnitude of 
one, and thus have no effect on the magnitude of the loop gain, they do however
add a phase shift. The time delay terms are = e' TpS, ŝ~ =  e~tpS, and
PaC02̂ Ŝ Pa02(S)
Poco2 ŝ) = e-v  t Wjth polar angles -cor , -cor , and —COT. respectively.
PaeM
Our three loop gain expressions are:
j  f l  - PpCQ2(S)  P<fcQ2(S) PgCQ2̂ S)  —C ' f  o~XPs __________ ( PICQ2 PgCQ2)Pc02
PC02 ~  —̂  -r=   'T' — y j p J 0 2  ' e
PaC02^) V J S )
~ S - ' ^ ---------------------~  P  0 2  f  ~  \
V  „  V A „  . S 1 T
Y I.C02
oT I '  A nr , TC02
, 5 J C 0 2 T t /  C02V 1+ s T~ i  rrt~>  a t  4l x T /y LC02 k 1 * i T C 0 2 j
LGC - ^~aCQ2( * ^ )  ^~aCQ2C1̂ )
l+s7?>
1+j TI\ TC 02
The model and loop gain analysis is based on work by Khoo et al. and 
Batzel and Tran (Batzel, Tran 2000, Khoo et al. 1982). We used this theory to 
calculate loop gain based on estimated parameter values for an awake four 
month old infant (Batzel, Tran 2000). To evaluate the effect that each parameter 
has on the loop gain we changed parameter values one at a time and calculated 
the resulting loop gain. Changing only one parameter is not physiologically 
accurate. If one parameter changes it will cause some of the others to also 
change. For instance, raising the inspired partial pressure of oxygen would cause 
the arterial partial pressure of oxygen to rise also. Nevertheless, this analysis 
gives us an idea of the parameters that have the greatest effect on loop gain.
The results are shown in Table 11. The parameters that had the greatest effect 
on the loop gain were (in decreasing order): P ao2, Paco2, Ip, P102, t p, G p , V lo 2 , and 
Tb. Central and peripheral control gains (G c  and G p ) can vary widely across 
individuals (Khoo et al. 1982). These results are typical of what is seen in 
periodic breathing modeling with excessive time delays, high gain factors, low 
lung volume, and large differences between inspired and arterial partial 
pressures all increasing loop gain and the peripheral chemoreceptors (G p  and Ip) 
having a much larger effect than the central chemoreceptors (G c  and lc )  
(Edwards, Sands & Berger 2013, Khoo et al. 1982).
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Table 11; Change in loop gain (parameter values for awake 4 month old)
parameter changed by: -15% -5% 5% 15%
parameter original value change in loop gain (from 0.16 at original values)
GP 2 liters/min/mmHg -13% -4% 4% 13%
Gc 0.1 liters/min/mmHg -0.4% -0 .1% 0 .1% 0 .2%
Ip 26 mmHg 34% 11% -11% -33%
Ic 26 mmHg -5% -2% 2% 4%
3 seconds -18% -6% 6% 16%
Tb 4 seconds 5% 2% -2% -6%
Q 1.16 liters/min 5% 2% - 1% -4%
VlC02 0.11 liters -1% -0.3% 0 .2% 1%
Vl02 0.92 liters 12% 4% -3% -9%
Pl02 150 mmHg -29% -10% 10% 30%
PaC02 34 mmHg -46% -15% 14% 38%
Pa02 96 mmHg 132% 32% -24% -53%
VD 0.54 liters/min -1% -0.4% 0.3% 1%
In all cases: Qb =0.24 liters/min, Vb=0.10 liters, PIco2=0 mmHg, V,Co2= 105 liters, 
Vto2=0-24 liters. Parameter values from Batzel and Tran (Batzel, Tran 2000).
During sleep Pao2. Q , and Qb are lower. In the asleep 1 case in Table 12
these parameter values are changed, with Q and Qb 5% lower than the awake 
1 case and Pao2=79 mmHg (Batzel, Tran 2000). In the asleep 1 case loop gain is 
higher but still less than one. Also shown in Table 12 are both an awake and an 
asleep case in which periodic breathing could arise. The parameter values for the 
awake 2 and the asleep 2 cases are based on changes that are seen for awake 
and asleep cases in adults in Khoo et al. (Khoo et al. 1982).
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Table 12: Parameter values for loop gain analysis
parameter unit awake 1 awake 2 asleep 1 asleep 2
GP liters/min/mmHg 2 2 2 2
Ip mmHg 26 26 26 26
Gc liters/min/mmHg 0.1 0.1 0.1 0.1
Ic mmHg 26 26 26 32*
seconds 3 3 3 3.5*
Tb seconds 4 4 4 4.5*
Q liters/min 1.16 1.16 1.10* 1.10
VlC02 liters 0.11 0.11 0.11 0.08*
Vl02 liters 0.092 0.092 0.092 0.07*
Pl02 mmHg 150 150 150 150
PaC02 mmHg 34 34 34 40*
P a02 mmHg 96 62* 79* 77*
VD liters/min 0.54 0.54 0.54 0.42*
Qb liters/min 0.24 0.24 0.228* 0.228
loop gain 0.16 1.2 0.44 1.04
* indicates a change from the preceding column
We have presented a model of periodic breathing in infants and analyzed 
stability in the model. Comparing the loop gain at 180° in the awake 1 case to the
loop gain in the asleep 1 case, where the values of Pao2. Q . and Qb have been 
decreased, shows that the loop gain increases from 0.16 to 0.44, bringing the 
loop gain closer to 1 where the system is unstable and periodic breathing could 
arise. In the awake 2 and the asleep 2 case the loop gain is greater than 1. 
Periodic breathing may arise in both while the infant is awake while the infant is 
asleep. Measurements of parameter values could help to determine infants who 
are more likely to have periodic breathing.
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Chapter 5
Clinical Correlates of Excessive Periodic 
Breathing
The periodic breathing detection algorithm was applied to the entire 
dataset. Our goals were to quantify periodic breathing in preterm infants 
throughout their stay in the NICU, and to identify clinical correlations with 
excessive periodic breathing. We focused our study of clinical correlations to 
infants who were <35 weeks’ gestation. 1372 infants <35 weeks’ gestation were 
admitted to the UVa NICU from 2009-2014. Data was available for periodic 
breathing analysis in 1268 of these infants. 1196 of them (94%) had some 
detected periodic breathing Figure 29.
When the periodic breathing detection algorithm was applied to the 
dataset the start time and duration of every detected event was recorded. At all 
times when data was available for analysis the percent of periodic breathing, 
defined as the time spent in periodic breathing divided by the amount of data 
available for analysis, was calculated. Time during which the infant was on a 
ventilator was excluded, as this prevents periodic breathing. We evaluated the 
amount of periodic breathing that infants had by gestational age. Figure 30 
shows the amount of periodic breathing by PMA and GA. We found that infants 
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Figure 29: Infants with data available for analysis and with periodic breathing detected
by gestational age (GA).
For gestational ages from 23 to 32 weeks periodic breathing increases with 
gestational age. Additionally, it was seen that periodic breathing typically peaks 
at about 2-4 weeks after birth. Figure 31 compares the percent of periodic 
breathing to the number of ABDIOs per day. Periodic breathing peaks at a 
postmenstrual age of 34 to 35 weeks, while ABDIOs peaks earlier.
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Figure 30: Mean percent o f time in periodic breathing for infants based on gestational
age and postmenstrual age
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Figure 31: Percent ofperiodic breathing and number of ABDIOs per day by 
postmenstrual age. Periodic breathing peaks at a later postmenstrual age than ABDIOs.
The results of our quantification of periodic breathing in our population of 
infants allowed us to establish what is a normal amount of periodic breathing. We 
used these results to find cases of excessive periodic breathing. We defined
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excessive periodic breathing as a z-score greater than 6 (more than 6 standard 
deviations above the mean for that GA and PMA) and at least 10% periodic 
breathing during a 12 hour period in which there was at least 6 hours of data 
available for analysis. By this definition extreme periodic breathing was identified 
in 76 infants. The clinical records of the 76 infants with excessive periodic 
breathing and the 1192 infants who had no excessive periodic breathing were 
examined. Table 13 compares the clinical characteristics in these two groups.
Table 13: Clinical characteristics of infants with and without excessive periodic 
breathing (PB) ____ _________
Demographics and clinical 
events
Excessive PB (n=76) No Extreme PB (n=1192)
median (25th-75th%) or n (%)
Gestational age (weeks) 28 (25-30) 32 (28-33)
Birthweight 1075 (833-1440) 1603(1120-2060)
Late onset sepsis 9(11.8%) 81 (6 .8%)
NEC 9(11.6%) 33 (2.8%)
Severe IVH 6 (7.9%) 45 (3.8%)
BPD 20 (26%) 223 (19%)
Death prior to NICU discharge 3 (3.9%) 47 (3.9%)
The clinical records of patients with excessive periodic breathing were 
also examined for clinical events that occurred within 24 hours of the 12 hour 
period when periodic breathing was the highest. In Table 14 it is shown that 34 
infants (45%) had some clinical event occurring within 24 hours of excessive 
periodic breathing. One infant died suddenly (of presumed sepsis) while in the 
NICU. This infant had excessive periodic breathing in the hours preceding death. 
Of the 42 infants for which there was no clinical event within 24 hours of the 
excessive periodic breathing episode, 4 had severe IVH and one died of SIDS
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five weeks after being discharged from the NICU. This is the only known case of 
SIDS after discharge from the UVa NICU.
Table 14: Clinical events near the time of excessive periodic breathing
Event Number
Late onset sepsis ± 24h 1
NEC ± 24h 1
Suspected infection or NEC ± 24h 8
Death within 24h 1
Surgery <24h prior 3
Immunization <24h prior 9
Caffeine stopped <8 days prior 11
No event identified 42
TOTAL 76
The patient who died of SIDS had periodic breathing almost continuously 
during her 2 week stay in the NICU and spent 40% of the time in periodic 
breathing from day 7 to 14 after birth (Figure 32). This patient was still spending 
36% of the time in periodic breathing at discharge. This patient was a twin. The 
twin of the infant who died of SIDS spent 15% of the time in periodic breathing 
during the second week of life. Other infants born at the same gestational age,
32 weeks, spent on average 5% of the time in periodic breathing during the 
second week of life. The patient who died of SIDS had no evidence of neurologic, 
cardiovascular, or other pathology based on her clinical course in the NICU or on 
autopsy. It was only on retrospective review of the patient’s data that the 
excessive amounts of periodic breathing were revealed.
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Figure 32: Percent ofperiodic breathing for SIDS infant and gestational age-matched 
infants. The percent of time spent in periodic breathing (time periodic breathing index >  
0.6 /  time data available) is shown based on post-menstrual age (PMA) for the infant that 
died of SIDS 2 weeks after NICU discharge, her twin sister, and all other infants born at 
32 weeks ’ gestation (n=68). The 25 th and 75 th percentiles every week for all other 
infants of 32 weeks' gestation are indicated with error bars (n=35-62). (Reproduced from 
Mohr et al. 2015a.)
Our analysis of extreme periodic breathing suggested an association 
between periodic breathing and necrotizing enterocolitis (NEC) and also periodic 
breathing and late onset sepsis (LOS). We identified all cases of NEC and LOS 
in the 1268 infants <35 weeks’ gestation with data available for periodic breathing 
analysis. Periodic breathing was evaluated in the 72 hours before diagnosis. We 
required that data was available for at least 50% of the time and excluded cases 
where infants were on a ventilator. There were 20 cases of NEC and 28 cases of 
LOS. Periodic breathing in the 24 hours before diagnosis was compared to the 
baseline value of periodic in the 78 to 24 hours before diagnosis. In 26 cases of 
LOS, periodic breathing increased in 11 cases. The increase was greater than
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two-fold in 9 cases. The Wilcoxon sign rank test was used to test whether there 
was a significant increase in periodic breathing in the 24 hours before diagnosis 
compared to the 24-72 hours before diagnosis. The p-value was >0.1, indicating 
that periodic breathing might often rise before LOS, but our data does not 
establish such a relationship to within the desired p-value of 0.05. In 20 cases of 
NEC, periodic breathing increased in 14 cases. In 8 cases of NEC the increase 
was greater than two-fold. The Wilcoxon sign rank test gives a p-value of 0.02, 
indicating that there may be a significant rise in the amount of periodic breathing 
before diagnosis of NEC.
The infant that died of presumed sepsis had over a 10-fold increase in 
periodic breathing in the 18 hours before death. Aside from this exceptional case, 
the correlation between increased periodic breathing seems to be greater with 
NEC than with sepsis. Figures 33 and 34 show increases in periodic breathing in 
cases of sepsis and NEC.
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Figure 33: Percent ofperiodic breathing (PB%) in the 78 hours before diagnosis o f LOS.
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Figure 34: Percent of periodic breathing (PB%) in the 78 hours before diagnosis of 
NEC.
Summary
A new method of detecting periodic breathing was presented. This method 
allowed us to quantify periodic breathing in a large number of infants over a long 
period of time. We found that periodic breathing increases with gestational age 
up to 32 weeks gestation, infants born at this age have the most periodic 
breathing. We identified infants that had excessive periodic breathing. Clinical 
correlations were analyzed in these infants. The clinical records of these infants 
were examined throughout their entire stay and after discharge. Correlations 
within 24 hours of the highest 12 hour period of periodic breathing were also
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analyzed. The results of these examination suggested possible correlations 
between periodic breathing and LOS or NEC. We studied 26 cases of LOS and 
20 cases of NEC. Periodic breathing increased before 11 cases of sepsis and 14 
cases of NEC. The correlation between increased periodic breathing and NEC 
appears to be strong among the study cohort. Real time analysis of periodic 
breathing in the NICU may result in earlier detection of some cases of NEC. Two 
infants who had excessive periodic breathing later died. One had high amounts 
of periodic breathing throughout her NICU course and died of SIDS after 
discharge. The other had excessive periodic breathing in the 18 hours before 
death of presumed sepsis. Excessive periodic breathing may be an indication of 




The data collected from the University of Virginia’s NICU over the past five 
years has allowed us to make advances in the detection of apnea and periodic 
breathing. Currently this detection is only taking place on the data after it is 
collected and stored. In the future we would like this detection to take place in 
real-time at the patient’s bedside. Our goal is to find new ways of predictive 
monitoring. Reliable detection of apnea and periodic breathing at the bedside is 
the next step in putting our findings into practice.
The study of very long apneas in infants led us to develop and test a 
theory of the rate of decrease of Sp02 in those events. The theory gives a good 
account of observations of averages of many events, and it works just as well for 
short events as for long events. We have not yet applied the theory to individual 
cases. This is potentially a very valuable thing to do. The theory could be used to 
fit the rate of decline of Sp02 to individual events in individual infants. Such a fit 
involves two parameters, the coefficient C in equation 2.2 (which is primarily 
related to cardiac output) and Sv, the venous oxygen saturation (which is affected 
by the respiration rate and the metabolism rate). Such fits might provide a means 
for monitoring those physiological parameters, which otherwise cannot be 
measured non-invasively.
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Turning now to periodic breathing, in the past, even large amounts of 
periodic breathing in NICU patients has largely gone unnoticed and unrecorded. 
Our work has raised awareness among the clinicians at University of Virginia and 
they now pay closer attention to periodic breathing. Running the periodic 
breathing detector real-time in the NICU would allow clinicians to see how much 
time an infant is been spending in periodic breathing and alert them to cases of 
excessive periodic breathing. It is reasonable to hope that real-time detection of 
periodic breathing could lead leads to early warning of NEC.
Fitting the model of periodic breathing to an individual infant’s data may 
allow us to determine the values of the parameters that are used in the periodic 
breathing model. Future studies could explore whether parameter values differ in 
infants who have excessive periodic breathing. It is possible that the infant who 
died of SIDS had abnormal parameter values that put the infant at risk for SIDS.
Future studies could also explore possible differences in the appearance 
of periodic breathing. We have not yet explored whether the cycle length is 
different in excessive periodic breathing. It would also be of interest to look at the 
breathing spells. These spells sometimes show a “spindle” pattern analogous to 
the “crescendo-diminuendo" pattern of Cheyn-Stokes breathing, and in other 
cases begin with a sudden deep breath that is larger in amplitude than those that 
follow. It is not known whether such distinctive patterns have clinical or 
physiological significance.
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Real-time detection of apnea events and of periodic breathing in 
the NICU, together with the application of mathematical models, may help 
us to uncover new knowledge of the physiology of infants, and may allow 




Table 15: Infant IDs, start times, and durations of VLAs. Start time is given as seconds 
from midnight. Days are measured continuously over the entire dataset. Duration is 
weighted apnea duration (WAD), area under probability o f apnea signal divided by 
duration of apnea. (See page 18 for definitions.)
ID WAD Day Start
1132 72 40 11348
1145 81 76 65708
1145 64 76 65925
1145 72 76 66064
1147 61 41 78682
1147 90 42 26769
1148 88 60 45101
1148 90 60 74766
1153 119 47 78341
1153 80 47 79819
1153 80 55 59302
1154 61 57 10327
1154 89 69 85629
1154 80 71 53899
1154 88 73 61938
1154 71 86 48683
1202 85 115 76317
1231 87 105 50852
1231 67 106 69566
1231 86 107 2457
1231 65 107 22152
1231 80 107 49305
1231 62 113 22446
1231 94 114 1720
1231 67 115 49848
1231 101 115 74516
1231 68 116 75890
1231 61 117 58296
1231 67 118 67560
1231 91 119 35901
1231 80 120 9907
1231 71 122 52983
1231 84 123 10063
1231 75 126 2665
1231 78 126 70351
1231 63 127 9573
1232 72 99 27516
1253 71 170 73168
1269 98 128 45080
1339 78 182 59465
1339 63 182 80014
1339 87 183 15970
1339 67 187 60791
ID WAD Day Start
1339 77 189 2222
1339 64 189 5853
1339 72 189 15734
1339 69 190 3963
1339 88 190 8152
1339 130 190 8683
1339 97 190 9429
1339 96 190 10351
1341 85 185 46446
1341 92 185 53230
1341 74 185 58246
1344 70 192 53031
1451 65 243 60025
1251 88 126 58901
1251 96 126 85973
1251 71 127 49219
1509 78 279 84136
1509 68 280 8787
1509 88 280 13706
1509 78 280 20481
1859 61 535 5236
1859 66 539 1358
1979 63 577 32891
2050 86 613 49057
2110 69 649 56573
2110 81 661 47811
2122 97 659 10460
2123 74 650 52350
2123 67 652 19641
2123 104 652 26778
2123 62 689 14444
2150 62 665 8912
2150 70 686 13998
2166 73 678 21918
2172 67 674 83095
2275 75 771 72912
2275 72 771 78434
2275 64 776 59849
2307 64 790 27627
2307 70 791 10922
2307 118 791 47112
2308 95 788 13884
2308 62 789 4648
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Appendix B
Table 16: Mean percent of time in periodic breathing (%) by gestational age and 
postmenstrual age____________________________________________________
Gestational age (weeks)
23 24 25 26 27 28 29 30 31 32 33 34 35
24 0.4 0.4 - -
25 0.3 0.4 0.4 -
26 0.3 0.4 0.4 0.4
27 0.4 0 .6 0.5 0.5 0.4 - - - - - - - -
inJ* 28 0.6 0.8 0.8 0.7 0.7 0.8 - - - - - - -<u0J 29 1 1 1 1 1.2 1.2 1.3 - - - - - -
30 1.2 1.1 1.1 1 1.4 1.4 1.4 1.1 - - - - -
bO 31 1.2 1.2 1.1 1.1 1.5 1.8 2 1.7 1.5 - - - -
32 1.5 1.5 1.3 1.4 1.9 2.5 2.9 2.8 2.7 2.6 - - -
33 1.7 1.6 1.3 1.6 2.3 3.1 3.4 3.8 4.2 3.8 3.6 - -
eu 34 1.6 1.7 1.4 1.9 2.3 2.9 3.2 3.9 5.2 4.9 4 3 -
■4-J 35 1.4 1.5 1.3 1.8 2 2.5 2.6 3.8 5.1 5.4 4.4 3.4 2.6
OCu 36 1.5 1.4 1.1 1.3 1.6 2.1 2.3 3.3 4.3 4.5 4.7 3.4 2.7
37 1.6 1.4 1.1 1 1.4 2 2.3 2.5 3.1 3.3 3.5 3.1 2.3
38 1.1 1 0.8 0.8 1.3 2.1 2.1 1.8 2 2.2 2.2 2.3 2.1
39 0.8 0.7 0.6 0.7 1.1 1.5 1.4 1 0.8 0.8 0.9 1.6 1.3
40 0.9 0.7 0.7 0.6 0.9 1.2 1.2 0.9 0.6 0.6 0 .6 1.3 1
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Table 17: Infant IDs and diagnosis times for infants with late onset sepsis.
Diagnosis time is given as seconds from midnight. Days are measured
continuous y over the entire dataset.
ID Case# Day Diagnosis time
1089 16 46 55560
1132 23 40 31860
1138 7 102 71100
1147 22 56 6300
1315 11 193 83580
1331 1 238 900
1341 10 244 0
1394 4 236 63840
1837 26 489 5760
1927 2 555 39600
1977 8 590 80100
1977 13 601 65340
2148 21 723 7200
2154 6 669 50400
2672 24 1030 7740
2690 3 1092 77160
2690 14 1142 48600
2945 17 1198 36660
2964 25 1223 60720
3183 20 1365 69180
3296 12 1434 0
3482 9 1550 55260
3598 18 1624 84540
3804 15 1730 39540
3837 19 1733 53280
3979 5 1840 71520
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Table 18: Infant IDs and diagnosis times for infants with necrotizing
enterocolitis. Diagnosis time is given as seconds from midnight. Days are
measured continuous y over the entire c
ID Case # Day Diagnosis time
1181 16 88 61020
1209 14 106 45120
1209 15 122 31020
1210 17 89 67020
1241 5 134 6480
1241 8 170 76980
1262 19 130 11760
1837 12 493 1860
2122 13 695 1920
2204 20 725 22020
2291 10 762 52260
2308 4 802 70560
2495 2 891 900
2957 7 1239 24960
3002 6 1235 25560
3076 18 1293 54300
3097 9 1306 51960
3187 1 1359 3000
3296 3 1434 49380
3385 11 1495 38100
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